<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Pharmaceuticals (Basel)</journal-id><journal-id journal-id-type="iso-abbrev">Pharmaceuticals (Basel)</journal-id><journal-id journal-id-type="publisher-id">pharmaceuticals</journal-id><journal-title-group><journal-title>Pharmaceuticals</journal-title></journal-title-group><issn pub-type="epub">1424-8247</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">40005965</article-id><article-id pub-id-type="pmc">PMC11860115</article-id><article-id pub-id-type="doi">10.3390/ph18020150</article-id><article-id pub-id-type="publisher-id">pharmaceuticals-18-00150</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Chemical Composition and Biological Activities of <italic toggle="yes">Lagopsis supina</italic> Extract: Antioxidant, Adipogenic, and Ani-Inflammatory Effects</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Choi</surname><given-names>Juhyun</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x02013; original draft</role><xref rid="af1-pharmaceuticals-18-00150" ref-type="aff">1</xref><xref rid="fn1-pharmaceuticals-18-00150" ref-type="author-notes">&#x02020;</xref></contrib><contrib contrib-type="author"><name><surname>Le</surname><given-names>Duc Dat</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x02013; original draft</role><xref rid="af2-pharmaceuticals-18-00150" ref-type="aff">2</xref><xref rid="fn1-pharmaceuticals-18-00150" ref-type="author-notes">&#x02020;</xref></contrib><contrib contrib-type="author"><name><surname>Roh</surname><given-names>Nayoung</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x02013; original draft</role><xref rid="af1-pharmaceuticals-18-00150" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0009-0001-6353-008X</contrib-id><name><surname>Lee</surname><given-names>Jiseok</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><xref rid="af1-pharmaceuticals-18-00150" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0009-0001-1456-8786</contrib-id><name><surname>Shrestha</surname><given-names>Deumaya</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><xref rid="af3-pharmaceuticals-18-00150" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name><surname>Dinh</surname><given-names>Thientam</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><xref rid="af2-pharmaceuticals-18-00150" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>Truong</surname><given-names>Vinhquang</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><xref rid="af2-pharmaceuticals-18-00150" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>Bazarragchaa</surname><given-names>Badamtsetseg</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Resources" vocab-term-identifier="https://credit.niso.org/contributor-roles/resources/">Resources</role><xref rid="af4-pharmaceuticals-18-00150" ref-type="aff">4</xref></contrib><contrib contrib-type="author"><name><surname>Kim</surname><given-names>Soo-Yong</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Resources" vocab-term-identifier="https://credit.niso.org/contributor-roles/resources/">Resources</role><xref rid="af5-pharmaceuticals-18-00150" ref-type="aff">5</xref></contrib><contrib contrib-type="author"><name><surname>Suh</surname><given-names>Sung-Suk</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; review &#x00026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review &#x00026; editing</role><xref rid="af1-pharmaceuticals-18-00150" ref-type="aff">1</xref><xref rid="af3-pharmaceuticals-18-00150" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-4187-3153</contrib-id><name><surname>Lee</surname><given-names>Mina</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Project administration" vocab-term-identifier="https://credit.niso.org/contributor-roles/project-administration/">Project administration</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role><xref rid="af2-pharmaceuticals-18-00150" ref-type="aff">2</xref><xref rid="af6-pharmaceuticals-18-00150" ref-type="aff">6</xref><xref rid="c1-pharmaceuticals-18-00150" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-5058-5156</contrib-id><name><surname>Seo</surname><given-names>Jong Bae</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Visualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/visualization/">Visualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Project administration" vocab-term-identifier="https://credit.niso.org/contributor-roles/project-administration/">Project administration</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role><xref rid="af1-pharmaceuticals-18-00150" ref-type="aff">1</xref><xref rid="af3-pharmaceuticals-18-00150" ref-type="aff">3</xref><xref rid="c1-pharmaceuticals-18-00150" ref-type="corresp">*</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>Iacopetta</surname><given-names>Domenico</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-pharmaceuticals-18-00150"><label>1</label>Department of Biomedicine, Health &#x00026; Life Convergence Sciences, BK21 Four, Biomedical and Healthcare Research Institute, Mokpo National University, Muan 58554, Jeonnam, Republic of Korea; <email>cjh000126@gmail.com</email> (J.C.); <email>youngna5201@naver.com</email> (N.R.); <email>leejisuk722@naver.com</email> (J.L.); <email>sungsuksuh@mokpo.ac.kr</email> (S.-S.S.)</aff><aff id="af2-pharmaceuticals-18-00150"><label>2</label>College of Pharmacy and Research Institute of Life and Pharmaceutical Sciences, Sunchon National University, 255 Jungangno, Suncheon 57922, Jeonnam, Republic of Korea; <email>ddle@scnu.ac.kr</email> (D.D.L.); <email>thientamm.2001@gmail.com</email> (T.D.); <email>quangvtruong00@gmail.com</email> (V.T.)</aff><aff id="af3-pharmaceuticals-18-00150"><label>3</label>Department of Biosciences, Mokpo National University, Muan 58554, Jeonnam, Republic of Korea; <email>sitamon2018@gmail.com</email></aff><aff id="af4-pharmaceuticals-18-00150"><label>4</label>Natural History Museum of Mongolia, Ulaanbaatar 15141, Mongolia; <email>batamtsetseg71@gmail.com</email></aff><aff id="af5-pharmaceuticals-18-00150"><label>5</label>International Biological Material Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon 34141, Republic of Korea; <email>soodole@kribb.re.kr</email></aff><aff id="af6-pharmaceuticals-18-00150"><label>6</label>Department of Natural Cosmetics Science and Natural Cosmetics Research Institute, Sunchon National University, 255 Jungangno, Suncheon 57922, Jeonnam, Republic of Korea</aff><author-notes><corresp id="c1-pharmaceuticals-18-00150"><label>*</label>Correspondence: <email>minalee@scnu.ac.kr</email> or <email>minalee@sunchon.ac.kr</email> (M.L.); <email>jbseo@mokpo.ac.kr</email> (J.B.S.); Tel.: +82-61-750-3764 (M.L.); +82-61-450-2348 (J.B.S.); Fax: +82-61-750-3708 (M.L.); +82-61-450-2349 (J.B.S.)</corresp><fn id="fn1-pharmaceuticals-18-00150"><label>&#x02020;</label><p>These authors contributed equally to this work.</p></fn></author-notes><pub-date pub-type="epub"><day>23</day><month>1</month><year>2025</year></pub-date><pub-date pub-type="collection"><month>2</month><year>2025</year></pub-date><volume>18</volume><issue>2</issue><elocation-id>150</elocation-id><history><date date-type="received"><day>29</day><month>12</month><year>2024</year></date><date date-type="rev-recd"><day>20</day><month>1</month><year>2025</year></date><date date-type="accepted"><day>20</day><month>1</month><year>2025</year></date></history><permissions><copyright-statement>&#x000a9; 2025 by the authors.</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>Background/Objectives: <italic toggle="yes">Lagopsis supina</italic>, a traditional Chinese medicine valued for its diuretic properties, has limited research on its antioxidant, adipogenic, and anti-inflammatory effects. This study aimed to investigate the chemical composition and biological activities of <italic toggle="yes">Lagopsis supina</italic> extract (LSE). Methods: LSE was prepared and evaluated for antioxidant activity, effects on adipocyte differentiation in 3T3-L1 preadipocytes, and anti-inflammatory properties in RAW 264.7 macrophages. Ultra-high-performance liquid chromatography-electrospray ionization Orbitrap tandem mass spectrometry (UHPLC-ESI-Orbitrap-MS/MS)-based molecular networking was used to characterize its secondary metabolites. Results: LSE exhibited antioxidant activity in DPPH and ABTS assays. It significantly enhanced the differentiation of 3T3-L1 preadipocytes into mature adipocytes during early and intermediate stages by upregulating adipogenic transcription factors such as PPAR&#x003b3;, C/EBP&#x003b1;, and C/EBP&#x003b2;, along with promoting cyclin E expression. LSE also increased PPAR&#x003b3; activity and the expression of its target genes, such as Glut 4, PEPCK, FABP4, and Plin2. Moreover, LSE inhibited lipopolysaccharide (LPS)-induced inflammation in RAW 264.7 macrophages by downregulating pro-inflammatory mediators (iNOS, COX-2, TNF-&#x003b1;, IL-6) and inhibiting extracellular signal-regulated kinase (ERK) phosphorylation. Chemical profiling revealed eight major compound groups: glycosides, organic acids, terpenoids, flavonoids, phenylglycosides, phenolics, fatty acids, and others characterized by their mass fragmentation patterns, precursors, and UV absorption spectra. In silico analysis confirmed these compounds&#x02019; bioactivities, demonstrating strong interactions and binding affinities with antioxidant, adipogenic, and anti-inflammatory protein targets. Conclusions: These findings highlight LSE&#x02019;s triple therapeutic potential: antioxidant activity, adipogenesis promotion, and inflammation attenuation. LSE emerges as a promising therapeutic candidate for managing obesity and related inflammatory complications.</p></abstract><kwd-group><kwd><italic toggle="yes">Lagopsis supina</italic></kwd><kwd>antioxidant</kwd><kwd>adipogenic transcription</kwd><kwd>UHPLC-MS/MS</kwd><kwd>inflammation</kwd></kwd-group><funding-group><award-group><funding-source>National Research Foundation of Korea (NRF) grants funded by the Korea government (MSIT)</funding-source><award-id>NRF-2019R1A2C1005719</award-id><award-id>RS-2022-NR070862</award-id></award-group><award-group><funding-source>Glocal University Project of Mokpo National University and Sunchon National University</funding-source></award-group><funding-statement>This research was funded by a National Research Foundation of Korea (NRF) grants funded by the Korea government (MSIT) (nos. NRF-2019R1A2C1005719 and RS-2022-NR070862). This research was also supported by Glocal University Project of Mokpo National University and Sunchon National University in 2024.</funding-statement></funding-group></article-meta></front><body><sec sec-type="intro" id="sec1-pharmaceuticals-18-00150"><title>1. Introduction</title><p>Obesity, a global public health challenge, is associated with an increased risk of numerous chronic diseases and health complications, either as an independent condition or in combination with other factors [<xref rid="B1-pharmaceuticals-18-00150" ref-type="bibr">1</xref>]. According to the World Health Organization (WHO), 39% of adults (1.9 billion) worldwide were classified as overweight in 2016, of whom 13% (over 650 million) were obese. Alarmingly, obesity also affected 340 million children and adolescents aged 5&#x02013;19 years and 24 million children under 5 years [<xref rid="B2-pharmaceuticals-18-00150" ref-type="bibr">2</xref>]. In 2019, a nationwide cross-sectional study in China revealed that nearly half the population was overweight or obese, with this prevalence directly linked to a surge in complications such as fatty liver disease, prediabetes, dyslipidemia, and hypertension [<xref rid="B3-pharmaceuticals-18-00150" ref-type="bibr">3</xref>]. Obesity notably amplifies the risk of morbidity and mortality, especially from cardiovascular disease (CVD) and diabetes, while contributing to a spectrum of chronic conditions, including osteoarthritis, liver and kidney disease, sleep apnea, and depression [<xref rid="B4-pharmaceuticals-18-00150" ref-type="bibr">4</xref>].</p><p>A key factor of obesity-related health issues is chronic, low-grade inflammation, which arises from adipose tissue expansion and disrupted insulin/mTORC2 signaling pathways. This inflammatory process underpins insulin resistance, pancreatic beta-cell dysfunction, and systemic metabolic dysregulation [<xref rid="B5-pharmaceuticals-18-00150" ref-type="bibr">5</xref>]. The inflammatory cascade begins with the recruitment of monocytes and the activation of pro-inflammatory macrophages, which secrete cytokines such as tumor necrosis factor-alpha (TNF-&#x003b1;) and interleukin-6 (IL-6). These cytokines amplify inflammation [<xref rid="B6-pharmaceuticals-18-00150" ref-type="bibr">6</xref>], perpetuating a cycle that exacerbates metabolic complications like type 2 diabetes [<xref rid="B7-pharmaceuticals-18-00150" ref-type="bibr">7</xref>].</p><p>Lipopolysaccharides (LPSs), commonly employed in vitro to simulate inflammatory responses, activate macrophages via Toll-like receptor 4 (TLR4) and MD-2 complexes. This activation triggers signaling through the mitogen-activated protein kinase (MAPK) pathways, including extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase, and p38. These pathways regulate the expression of critical inflammatory mediators such as inducible nitric oxide synthase (iNOS), cyclooxygenase-2 (COX-2), and cytokines like TNF-&#x003b1; and IL-6 [<xref rid="B8-pharmaceuticals-18-00150" ref-type="bibr">8</xref>]. Nitric oxide (NO), produced by iNOS, serves as both a marker and a contributor to the pathophysiology of obesity-driven inflammation [<xref rid="B9-pharmaceuticals-18-00150" ref-type="bibr">9</xref>]. Innovative therapeutic strategies that target MAPK phosphorylation, iNOS, and COX-2 within macrophages represent promising avenues for reducing the inflammatory burden of obesity and its associated complications [<xref rid="B10-pharmaceuticals-18-00150" ref-type="bibr">10</xref>].</p><p><italic toggle="yes">Lagopsis supina</italic> (Steph.) Ik.-Gal., a traditional Chinese medicine predominantly found in Northern China, including Ningxia, Shanxi, Gansu, Henan, and Shaanxi provinces, has long been used to treat ailments such as oligomenorrhea, hemiplegia, blood stagnation, amenorrhea, anemic dizziness, and inflammation and as a diuretic [<xref rid="B11-pharmaceuticals-18-00150" ref-type="bibr">11</xref>,<xref rid="B12-pharmaceuticals-18-00150" ref-type="bibr">12</xref>,<xref rid="B13-pharmaceuticals-18-00150" ref-type="bibr">13</xref>,<xref rid="B14-pharmaceuticals-18-00150" ref-type="bibr">14</xref>,<xref rid="B15-pharmaceuticals-18-00150" ref-type="bibr">15</xref>]. Recent research reveals that <italic toggle="yes">L</italic>. <italic toggle="yes">supina</italic> extract (LSE) mitigates myocardial infarction damage in vivo by promoting angiogenesis, reducing oxidative stress, and modulating inflammation through pathways such as VEGF and HMGB1 [<xref rid="B16-pharmaceuticals-18-00150" ref-type="bibr">16</xref>]. LSE comprises over 80 identified compounds, including diterpenoids, phenylethanoid glycosides, and flavonoid glycosides [<xref rid="B11-pharmaceuticals-18-00150" ref-type="bibr">11</xref>,<xref rid="B17-pharmaceuticals-18-00150" ref-type="bibr">17</xref>,<xref rid="B18-pharmaceuticals-18-00150" ref-type="bibr">18</xref>,<xref rid="B19-pharmaceuticals-18-00150" ref-type="bibr">19</xref>]. While studies have documented its diuretic [<xref rid="B17-pharmaceuticals-18-00150" ref-type="bibr">17</xref>,<xref rid="B19-pharmaceuticals-18-00150" ref-type="bibr">19</xref>], anti-inflammatory [<xref rid="B12-pharmaceuticals-18-00150" ref-type="bibr">12</xref>,<xref rid="B20-pharmaceuticals-18-00150" ref-type="bibr">20</xref>], and anti-neuroinflammatory properties [<xref rid="B21-pharmaceuticals-18-00150" ref-type="bibr">21</xref>], its influence on adipocyte differentiation and macrophage-driven inflammation remains unexamined.</p><p>This study explored the therapeutic potential of LSE in managing oxidative stress and obesity-related inflammation. Using in vitro models, we evaluated its radical scavenging activity, impact on adipocyte differentiation in 3T3-L1 cells, and anti-inflammatory effects in LPS-stimulated RAW 264.7 macrophages. LSE was found to enhance adipogenesis and lipogenesis in 3T3-L1 cells while significantly inhibiting LPS-induced nitric oxide (NO) production in RAW 264.7 macrophages, likely through the modulation of MAPK phosphorylation, iNOS, and COX-2. Moreover, a UHPLC-ESI-Orbitrap-MS/MS-based molecular networking approach, integrated with open-platform-guided isolation and dereplication, enabled the identification of bioactive metabolites in LSE. Molecular docking further highlighted the strong binding affinities of key components to target proteins involved in adipogenesis and inflammation. These findings suggest that LSE has significant potential as a natural therapeutic agent for addressing the inflammatory underpinnings of obesity and its associated metabolic disorders.</p></sec><sec sec-type="results" id="sec2-pharmaceuticals-18-00150"><title>2. Results</title><sec id="sec2dot1-pharmaceuticals-18-00150"><title>2.1. Antioxidative Capacity of LSE Through Radical Scavenging Activity</title><p>To evaluate the antioxidant capacity of LSE, DPPH and ABTS assays were conducted to measure free radical scavenging activities. The scavenging activity was expressed as the percentage inhibition of DPPH and ABTS radicals. <xref rid="pharmaceuticals-18-00150-f001" ref-type="fig">Figure 1</xref>A,B depicts the average scavenging percentages for DPPH and ABTS at varying LSE concentrations. The findings indicate that LSE&#x02019;s radical scavenging activity increases with concentration. At 150 &#x000b5;g/mL, LSE demonstrated a moderate inhibition of 31.44% &#x000b1; 0.73% compared to ascorbic acid (AA), the standard antioxidant, which achieved a significant DPPH inhibition of 62.26% &#x000b1; 1.20%. Similarly, for ABTS, LSE showed an inhibition of 65.03% &#x000b1; 1.40% at 150 &#x000b5;g/mL, while AA exhibited a potent inhibitory activity of 99.36% &#x000b1; 0.02%. The IC<sub>50</sub> values derived from the DPPH and ABTS assays support these results, with LSE showing higher IC<sub>50</sub> values (234.5 &#x003bc;g/mL for DPPH and 109.4 &#x003bc;g/mL for ABTS), indicative of lower antioxidant potential. Compared to synthetic AA, LSE exhibits moderate antioxidant activity.</p></sec><sec id="sec2dot2-pharmaceuticals-18-00150"><title>2.2. LSE Stimulates 3T3-L1 Adipocyte Differentiation Without Cytotoxicity</title><p>To assess the cytotoxicity of LSE in 3T3-L1 preadipocytes, a WST-8 cell viability assay was performed. As shown in <xref rid="app1-pharmaceuticals-18-00150" ref-type="app">Figure S1A</xref>, treatment with 10&#x02013;200 &#x003bc;g/mL LSE for 24 h did not significantly affect cell viability, indicating that LSE is non-toxic to 3T3-L1 preadipocytes under these conditions. Adipocyte differentiation was evaluated using induction media containing varying concentrations of a standard differentiation cocktail: 3-isobutyl-1-methylxanthine, dexamethasone, and insulin (MDI). Post-confluent 3T3-L1 preadipocytes were treated with 0.17&#x000d7;, 0.33&#x000d7;, or 1&#x000d7; MDI during adipogenesis. Oil red O staining revealed a concentration-dependent increase in intracellular lipid accumulation (<xref rid="app1-pharmaceuticals-18-00150" ref-type="app">Figure S1B</xref>). Additionally, the expression of adipocyte-specific genes, including PPAR&#x003b3;, FABP4, and adiponectin, was significantly elevated in cells treated with higher MDI concentrations, consistent with the lipid staining results (<xref rid="app1-pharmaceuticals-18-00150" ref-type="app">Figure S1C</xref>). Differentiated adipocytes in the 0.17 &#x000d7; MDI-treated group represented about 25% of those in the 1 &#x000d7; MDI-treated group. Based on these findings, 0.17 &#x000d7; MDI was selected as the induction medium for subsequent experiments on LSE&#x02019;s effect on adipocyte differentiation.</p><p>To investigate LSE&#x02019;s impact on adipogenesis, 3T3-L1 preadipocytes were treated with LSE at 30, 50, and 100 &#x003bc;g/mL in differentiation media. Oil red O staining showed a significant, dose-dependent increase in lipid accumulation in LSE-treated cells compared to untreated controls (<xref rid="pharmaceuticals-18-00150-f001" ref-type="fig">Figure 1</xref>C). These results suggest LSE promotes preadipocyte maturation into adipocytes without inducing cytotoxicity.</p><p>To elucidate the underlying mechanisms, qRT-PCR analysis assessed adipogenic gene expression. LSE treatment induced a dose-dependent upregulation of PPAR&#x003b3;, C/EBP&#x003b1;, C/EBP&#x003b2;, adiponectin, and FABP4 compared to controls (<xref rid="pharmaceuticals-18-00150-f001" ref-type="fig">Figure 1</xref>D). Western blot analysis confirmed these results, showing increased protein expression of PPAR&#x003b3; and adiponectin in a dose-dependent manner (<xref rid="pharmaceuticals-18-00150-f001" ref-type="fig">Figure 1</xref>E). LSE treatment also significantly upregulated lipogenic genes, including FAS, SCD-1, SCD-2, and ACC (<xref rid="pharmaceuticals-18-00150-f001" ref-type="fig">Figure 1</xref>F). These findings collectively demonstrate that LSE promotes 3T3-L1 preadipocyte differentiation into mature adipocytes by upregulating genes associated with adipogenesis and lipogenesis.</p></sec><sec id="sec2dot3-pharmaceuticals-18-00150"><title>2.3. LSE Exhibits Enhanced Effects on Adipocyte Differentiation During Early and Intermediate Stages</title><p>To pinpoint the specific stage of adipocyte differentiation most influenced by LSE, preadipocytes were treated with LSE at different time points during the differentiation process (<xref rid="pharmaceuticals-18-00150-f002" ref-type="fig">Figure 2</xref>A). As shown in <xref rid="pharmaceuticals-18-00150-f002" ref-type="fig">Figure 2</xref>B, Oil red O staining revealed that treatment during the early stages (conditions 2, 5, and 7) resulted in the most pronounced lipid accumulation in adipocytes, followed by treatment during the intermediate stages (conditions 3 and 6). In contrast, treatment during the late stage (condition 4) had the least effect compared to the untreated control group (condition 1). qRT-PCR analysis showed a significant upregulation of adipogenic markers, including PPAR&#x003b3;, C/EBP&#x003b1;, C/EBP&#x003b2;, FABP4, and adiponectin, in all treatment groups relative to controls, with the most substantial increase observed in the early and intermediate treatment groups (<xref rid="pharmaceuticals-18-00150-f002" ref-type="fig">Figure 2</xref>C). Western blot analysis confirmed these findings, showing elevated protein levels of PPAR&#x003b3; and adiponectin in early and intermediate treatment groups, with minimal changes in the late-stage group (<xref rid="pharmaceuticals-18-00150-f002" ref-type="fig">Figure 2</xref>D). Similarly, lipogenic gene expressions, including SCD1, SCD2, FAS, and ACC, were significantly upregulated in early and intermediate treatment groups (<xref rid="pharmaceuticals-18-00150-f002" ref-type="fig">Figure 2</xref>E). These results indicate that LSE exerts its strongest influence on adipocyte differentiation when applied during the early and intermediate stages of the process.</p></sec><sec id="sec2dot4-pharmaceuticals-18-00150"><title>2.4. LSE Promotes Adipocyte Differentiation Through Enhanced Expression of Key Regulatory Genes</title><p>To explore the mechanisms underlying LSE-induced adipocyte differentiation, we examined the expression of key regulatory genes. LSE treatment during the initial differentiation stages (Day 0&#x02013;2) significantly increased mRNA levels of C/EBP&#x003b2;, PPAR&#x003b3;, and C/EBP&#x003b1;, essential transcription factors for adipocyte formation (<xref rid="pharmaceuticals-18-00150-f003" ref-type="fig">Figure 3</xref>A).</p><p>Additionally, LSE treatment upregulated cyclin E mRNA expression, a protein critical for mitotic clonal expansion (MCE), a prerequisite for preadipocyte differentiation (<xref rid="pharmaceuticals-18-00150-f003" ref-type="fig">Figure 3</xref>B). This suggests that LSE not only activates adipogenic gene transcription but also facilitates preadipocyte proliferation by enhancing cell cycle progression. Notably, the expression of CHOP, a negative regulator of adipocyte differentiation, remained unchanged at both mRNA and protein levels following LSE treatment (<xref rid="pharmaceuticals-18-00150-f003" ref-type="fig">Figure 3</xref>C,D), suggesting that LSE promotes differentiation through a CHOP-independent pathway. Collectively, these findings demonstrate that LSE enhances adipocyte development by promoting the expression of key regulatory genes and supporting cell division processes critical for differentiation.</p></sec><sec id="sec2dot5-pharmaceuticals-18-00150"><title>2.5. LSE Stimulates PPAR&#x003b3; Activity and Upregulates PPAR&#x003b3; Target Genes</title><p>PPAR&#x003b3; is a critical transcription factor in adipocyte differentiation. To assess whether LSE modulates PPAR&#x003b3; activity, a luciferase reporter assay was performed using a PPRE-containing reporter construct that binds the PPAR&#x003b3;/RXR&#x003b1; heterodimer. As shown in <xref rid="pharmaceuticals-18-00150-f003" ref-type="fig">Figure 3</xref>E, rosiglitazone, a known PPAR&#x003b3; agonist, significantly enhanced luciferase activity, serving as a positive control. Similarly, LSE increased luciferase activity in a concentration-dependent manner, demonstrating its ability to directly regulate PPAR&#x003b3; activity. To further evaluate LSE&#x02019;s effects on PPAR&#x003b3;-mediated gene expression, the expression levels of key target genes, including glucose transporter 4 (Glut4), phosphoenolpyruvate carboxykinase (PEPCK), fatty acid-binding protein 4 (FABP4), and perilipin-2 (Plin2), were evaluated in differentiated adipocytes following LSE treatment (<xref rid="pharmaceuticals-18-00150-f003" ref-type="fig">Figure 3</xref>F). LSE significantly upregulated these target genes, reinforcing its role in activating PPAR &#x003b3; and promoting adipocyte differentiation.</p></sec><sec id="sec2dot6-pharmaceuticals-18-00150"><title>2.6. Cytotoxicity and Nitric Oxide (NO) Inhibitory Activity of LSE in RAW264.7 Macrophages</title><p>To assess the cytotoxicity of LSE, RAW264.7 cells were treated with concentrations ranging from 30 to 300 &#x000b5;g/mL. Cell viability assays confirmed that LSE was non-toxic, even at the highest concentration (300 &#x000b5;g/mL) (<xref rid="pharmaceuticals-18-00150-f004" ref-type="fig">Figure 4</xref>A). The anti-inflammatory properties of LSE were then evaluated by measuring NO production in LPS-stimulated RAW264.7 cells. LSE treatment reduced NO production in a dose-dependent manner, with the highest concentration (300 &#x000b5;g/mL) exhibiting a stronger inhibitory effect than the anti-inflammatory agent N-acetylcysteine (NAC) (<xref rid="pharmaceuticals-18-00150-f004" ref-type="fig">Figure 4</xref>B). These findings establish LSE as a safe and potent modulator of inflammatory responses in macrophages.</p></sec><sec id="sec2dot7-pharmaceuticals-18-00150"><title>2.7. Molecular Mechanisms Underlying the Anti-Inflammatory Effect of LSE</title><p>To investigate the molecular mechanisms underlying LSE&#x02019;s anti-inflammatory effects, we analyzed the expression of key inflammatory mediators and the involvement of specific signaling pathways. qRT-PCR analysis showed that LSE treatment significantly downregulated pro-inflammatory genes, including iNOS, COX-2, TNF-&#x003b1;, and IL-6, in a dose-dependent manner in LPS-stimulated RAW264.7 macrophages (<xref rid="pharmaceuticals-18-00150-f004" ref-type="fig">Figure 4</xref>C). Western blot analysis confirmed these findings, revealing reduced protein levels of iNOS and COX-2 after LSE treatment, with effects more pronounced than those of the anti-inflammatory agent NAC (<xref rid="pharmaceuticals-18-00150-f004" ref-type="fig">Figure 4</xref>D).</p><p>To investigate the molecular basis of LSE&#x02019;s anti-inflammatory effects, its impact on the ERK signaling pathway, a critical regulator of inflammation, was assessed. Western blot analysis revealed that LSE pretreatment significantly inhibited LPS-induced phosphorylation of ERK (p-ERK) in RAW264.7 macrophages (<xref rid="pharmaceuticals-18-00150-f004" ref-type="fig">Figure 4</xref>E). Notably, NAC did not alter p-ERK levels, indicating that LSE specifically suppresses inflammatory responses by attenuating ERK phosphorylation. These findings suggest that LSE exerts its anti-inflammatory effects through a dual mechanism: the downregulation of pro-inflammatory mediators and the inhibition of ERK signaling.</p></sec><sec id="sec2dot8-pharmaceuticals-18-00150"><title>2.8. Identification of Metabolites from LSE</title><p>The chemical profile of LSE was analyzed using UHPLC-Orbitrap-MS/MS, generating ion chromatograms in negative mode (<xref rid="app1-pharmaceuticals-18-00150" ref-type="app">Figure S2, Supplementary Materials</xref>). Peaks were well separated with precursor masses reaching approximately 1500 Da. To identify secondary metabolites (<xref rid="pharmaceuticals-18-00150-t001" ref-type="table">Table 1</xref>), data from the UHPLC-Orbitrap-MS/MS system analysis underwent support by GNPS open web tools for feature-based molecular networking visualization (<xref rid="pharmaceuticals-18-00150-f005" ref-type="fig">Figure 5</xref>). Nodes in the molecular network were clustered based on similar isotope patterns of precursors.</p><p>Cluster A highlighted the presence of two major phenylglycosides: [(2<italic toggle="yes">R</italic>,3<italic toggle="yes">R</italic>,4<italic toggle="yes">R</italic>,5<italic toggle="yes">R</italic>,6<italic toggle="yes">R</italic>)-2-[[(2<italic toggle="yes">R</italic>,3<italic toggle="yes">R</italic>,4<italic toggle="yes">R</italic>)-3,4-dihydroxy-4-(hydroxymethyl) oxolan-2-yl]oxymethyl-4-[(2<italic toggle="yes">S</italic>,3<italic toggle="yes">R</italic>,4<italic toggle="yes">R</italic>,5<italic toggle="yes">R</italic>,6<italic toggle="yes">S</italic>)-4,5-dihydroxy-6-methyl-3-[(2<italic toggle="yes">S</italic>,3<italic toggle="yes">R</italic>,4<italic toggle="yes">S</italic>,5<italic toggle="yes">S</italic>)-3,4,5-trihydroxyoxan-2-yl]oxyoxan-2-yloxy-6-[2-(3,4-dihydroxyphenyl)ethoxy]-5-hydroxyoxan-3-yl] (<italic toggle="yes">E</italic>)-3-(3,4-dihydroxyphenyl)prop-2-enoate and acteoside. These compounds, observed at <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 755.2393 [M-H]<sup>&#x02212;</sup> and <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 623.1972 [M-H]<sup>&#x02212;</sup>, respectively, were identified as major constituents of <italic toggle="yes">L</italic>. <italic toggle="yes">supina</italic> [<xref rid="B22-pharmaceuticals-18-00150" ref-type="bibr">22</xref>]. Cluster D revealed nodes corresponding to quinic acid derivatives with specific fragments at <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 191 [M-H]<sup>&#x02212;</sup>. These included precursor ion peaks at <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 367.1028 [M-H]<sup>&#x02212;</sup>, 353.0872 [M-H], and 337.0927 [M-H]<sup>&#x02212;</sup>, indicating the presence of organic acids such as 3-<italic toggle="yes">O</italic>-feruloylquinic acid, neochlorogenic acid, and coumaroyl quinic acid, respectively. Proposed biosynthetic pathways suggest that 3-<italic toggle="yes">O</italic>-feruloylquinic acid undergoes demethylation to form neochlorogenic acid via methyl group reduction. Neochlorogenic acid, in turn, may lose a water molecule to produce coumaroyl quinic acid [<xref rid="B23-pharmaceuticals-18-00150" ref-type="bibr">23</xref>]. Cluster J displayed nodes with precursor ion peaks at <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 327.2173 [M-H]<sup>&#x02212;</sup> and at <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 329.2329 [M-H]<sup>&#x02212;</sup>, assigned to fatty acids identified as (<italic toggle="yes">Z</italic>)-9,12,13-trihydroxyoctadec-15-enoic acid and 2-(2-acetyloxy-12-hydroxytridecyl)-4,6-dihydroxybenzoic acid, respectively [<xref rid="B22-pharmaceuticals-18-00150" ref-type="bibr">22</xref>]. It is proposed that these compounds may interconvert by exchanging two hydrogen atoms during biosynthetic processing. Cluster M showed a major peak at <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 457.2798 [M-H], corresponding to [4,5-dihydroxy-3,4-bis(hydroxymethyl)-4a,8,8-trimethyl-5,6,7,8a-tetrahydro-1H-naphthalen-1-yl]octanoate. Cluster X displayed nodes associated with flavonoid glycosides, categorized into kaempferol and quercetin backbones. The peaks detected at <italic toggle="yes">t</italic><sub>R</sub> of 8.808, 9.596, 10.825, 11.842, and 14.111 min shared a mass fragment at <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 284 [M-H]<sup>&#x02212;</sup>, corresponding to the kaempferol backbone. Their precursor ions were observed at <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 739.2083, 593.1505, 447.0926, 417.0822, and 593.1293 [M-H]<sup>&#x02212;</sup>, identified as 3-[4,5-dihydroxy-3-[(2<italic toggle="yes">R</italic>,3<italic toggle="yes">R</italic>,4<italic toggle="yes">R</italic>,5<italic toggle="yes">R</italic>,6<italic toggle="yes">S</italic>)-3,4,5-trihydroxy-6-methyloxan-2-yl].oxy-6-[[(2<italic toggle="yes">R</italic>,3<italic toggle="yes">R</italic>,4<italic toggle="yes">R</italic>,5<italic toggle="yes">R</italic>,6<italic toggle="yes">S</italic>)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxy-5,7-dihydroxy-2-(4-hydroxyphenyl)chromen-4-one; kaempferol 3-<italic toggle="yes">O</italic>-neohesperidoside; kaempferol-3-<italic toggle="yes">O</italic>-glucoside; kaempferol-3-<italic toggle="yes">O</italic>-arabinoside; and tribuloside, respectively. The biosynthetic pathway suggests that these secondary metabolites undergo deglycosylation to reduce molecular weight, converting the peak at <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 739.2083 [3-[4,5-dihydroxy-3-[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy-6-[[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxy-5,7-dihydroxy-2-(4-hydroxyphenyl)chromen-4-one] to <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 593.1505 [kaempferol 3-<italic toggle="yes">O</italic>-neohesperidoside] by removing a rhamnosyl molecule.</p><p>A fragmentation pathway was similarly observed for the peak at <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 593.1505 [kaempferol 3-<italic toggle="yes">O</italic>-neohesperidoside], which transitions to the peak at <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 447.0926 through the loss of a rhamnosyl molecule, forming kaempferol-3-<italic toggle="yes">O</italic>-glucoside. Subsequently, the peak at <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 447.0926 reduces a methylene-hydroxy group to produce the peak at <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 417.0822, corresponding to kaempferol-3-<italic toggle="yes">O</italic>-arabinoside [<xref rid="B24-pharmaceuticals-18-00150" ref-type="bibr">24</xref>]. The peaks detected at <italic toggle="yes">t</italic><sub>R</sub> of 8.213, 9.405, 9.896, and 10.774 min showed the same daughter peak at <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 301 [M-H]<sup>&#x02212;</sup>, indicating the quercetin backbone. It is proposed that the peak at <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 739.2083 [3-[4,5-dihydroxy-3-[(2<italic toggle="yes">R</italic>,3<italic toggle="yes">R</italic>,4<italic toggle="yes">R</italic>,5<italic toggle="yes">R</italic>,6<italic toggle="yes">S</italic>)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy-6-[[(2<italic toggle="yes">R</italic>,3<italic toggle="yes">R</italic>,4<italic toggle="yes">R</italic>,5<italic toggle="yes">R</italic>,6<italic toggle="yes">S</italic>)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxy-5,7-dihydroxy-2-(4-hydroxyphenyl) chromen-4-one] undergoes hydroxylation to produce the ion peak at <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 755.2034 [Manghaslin]. This peak further generates the ion peak at <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 609.1454 [M-H]<sup>&#x02212;</sup> via deglycosylation, forming rutin [<xref rid="B25-pharmaceuticals-18-00150" ref-type="bibr">25</xref>]. A biosynthetic transformation pathway was observed where the peak at <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 609.1454 transitions to peaks at <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 463.0875 and <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 433.0769 through successive reductions of a rhamosyl molecule and a methylene-hydroxy group, respectively. The remaining peaks in the chromatograms were annotated using the MS-Dial program version 5.1.230912, comparing experimental mass data with public mass databanks. The precursor ion peaks at <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 409.2223 [M-H]<sup>&#x02212;</sup> and at <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 409.2224 [M-H]<sup>&#x02212;</sup> were identified as the terpenoid compounds forskolin and 1-<italic toggle="yes">epi</italic> coleonol, respectively. Another prominent terpenoid peak at <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 393.2276 [M-H]<sup>&#x02212;</sup> was identified as grayanotoxin I by interpreting its mass spectrum in conjunction with mass databanks. Additional compounds were identified by dereplication of mass precursors and fragmentation patterns, alongside comparisons with previous reports, an in-house library, or public mass databanks.</p><p>To estimate the metabolite content in the extract, the analytical data were processed based on peak areas from chromatograms in negative ion mode. Peaks 55, 57, 85, 88, 91, 101, 106, 108, 109, and 113 were identified as major peaks, exhibiting higher content relative to others in the chromatogram (<xref rid="app1-pharmaceuticals-18-00150" ref-type="app">Figure S3, Supplementary Materials</xref>).</p></sec><sec id="sec2dot9-pharmaceuticals-18-00150"><title>2.9. Molecular Docking Analysis</title><p>To evaluate the biological potential of the extract, in silico studies were conducted to predict the activity of major compounds against antioxidant, adiponectin, PPAR&#x003b3;, IL-6, TNF-&#x003b1;, iNOS, COX-2, and ERK proteins using the AutoDock4.0 program. Initially, docking protocols were validated by redocking native ligands into protein&#x02013;ligand complexes. The root mean square deviation between the original and redocked ligands was calculated to be less than 2 &#x000c5;, confirming the accuracy of the docking procedure. When major peaks were docked into the 1HCK protein, the ligands and redocked native ligands occupied the same binding pose within the protein, validating the reliability of the docking protocol (<xref rid="app1-pharmaceuticals-18-00150" ref-type="app">Figure S4, Supplementary Materials</xref>). Among the compounds tested, peak 55 exhibited the lowest binding energy (&#x00394;G = &#x02212;12.18 kcal/mol), followed by peaks 101 (&#x00394;G = &#x02212;10.77 kcal/mol), 113 (&#x00394;G = &#x02212;10.53 kcal/mol), 91 (&#x00394;G = &#x02212;10.50 kcal/mol), 109 (&#x00394;G = &#x02212;10.47 kcal/mol), 57 (&#x00394;G = &#x02212;10.03 kcal/mol), 108 (&#x00394;G = &#x02212;9.83 kcal/mol), 85 (&#x00394;G = &#x02212;8.70 kcal/mol), 88 (&#x00394;G = &#x02212;8.23 kcal/mol), and 106 (&#x00394;G = &#x02212;7.59 kcal/mol) (<xref rid="pharmaceuticals-18-00150-f006" ref-type="fig">Figure 6</xref>). These results suggest that hydrogen bonds with key residues, such as THR14 and TYR15, are critical for interactions.</p><p>When docked into the adiponectin protein, all major peaks were positioned within the same region of the ligand&#x02013;protein binding pocket. Peak 57 displayed the lowest binding energy (G = &#x02212;13.43 kcal/mol), followed by peaks 109, 91, 106, 108, and 55, with scores ranging from &#x02212;12.59 to &#x02212;11.10 kcal/mol. Peaks 85, 88, 113, and 101 showed binding energies between &#x02212;9.50 kcal/mol and &#x02212;6.45 kcal/mol (<xref rid="pharmaceuticals-18-00150-f007" ref-type="fig">Figure 7</xref>). The major peaks also showed strong binding affinities for the PPAR&#x003b3; protein. Peaks 55, 57, and 109 demonstrated significant docking scores (G = &#x02212;14.04, &#x02212;11.25, and &#x02212;12.13 kcal/mol, respectively), outperforming the redocked native ligand BRL (G = &#x02212;12.53 kcal/mol). Peaks 85, 88, 91, 101, 108, and 113 exhibited binding affinities with scores ranging from &#x02212;9.98 to &#x02212;6.42 kcal/mol (<xref rid="pharmaceuticals-18-00150-f008" ref-type="fig">Figure 8</xref>). When docked into iNOS protein, all major peaks occupied the binding pose within the ligand&#x02013;protein complexes, confirming their potential as ligands for these targets.</p><p>Among the tested compounds, peaks 55, 91, 101, 108, 109, and 113 displayed significant binding scores (&#x00394;G, from 12.39 to &#x02212;8.06 kcal/mol) compared to the redocked native ligand (AT2, G = &#x02212;8.18 kcal/mol) (<xref rid="pharmaceuticals-18-00150-f009" ref-type="fig">Figure 9</xref>). These peaks also docked into the COX-2 protein, occupying the same binding pocket as the complexes. Peaks 55, 57, 109, and 113 demonstrated lower docking scores (G = &#x02212;12.08, &#x02212;12.45, &#x02212;10.39, and &#x02212;10.18 kcal/mol, respectively) than the redocked native ligand (JMS, G = &#x02212;10.11 kcal/mol) (<xref rid="pharmaceuticals-18-00150-f010" ref-type="fig">Figure 10</xref>).</p><p>Additionally, peaks 85, 91, and 108 showed significant scores (&#x00394;G = &#x02212;9.94 to &#x02212;9.27 kcal/mol), outperforming the redocked ligand. When docked into IL-6 protein, most major peaks occupied the same binding pocket region as the IL-6 inhibitor madindoline A, except for peak 106. Peaks 55, 57, 101, 108, 109, and 113 displayed higher binding affinities (&#x00394;G, ranging from &#x02212;10.50 to &#x02212;8.12 kcal/mol) compared to madindoline A (&#x00394;G = &#x02212;8.08 kcal/mol) (<xref rid="pharmaceuticals-18-00150-f011" ref-type="fig">Figure 11</xref>). Similarly, these major peaks occupied the same binding poses within TNF-&#x003b1; protein complexes, with docking scores (&#x00394;G) ranging from &#x02212;12.23 to &#x02212;6.31 kcal/mol, outperforming the redocked native ligand (307, G = &#x02212;10.22 kcal/mol) (<xref rid="pharmaceuticals-18-00150-f012" ref-type="fig">Figure 12</xref>). When docked into ERK protein, the major peaks exhibited significant binding scores (&#x00394;G) ranging from &#x02212;8.32 to &#x02212;4.60 kcal/mol) exceeding the redocked native ligand (KJ4, G = &#x02212;4.92 kcal/mol) (<xref rid="pharmaceuticals-18-00150-f013" ref-type="fig">Figure 13</xref>). These results suggest that the major peaks exhibit strong binding affinity, potentially enhancing the bioactivities of the extract.</p></sec></sec><sec sec-type="discussion" id="sec3-pharmaceuticals-18-00150"><title>3. Discussion</title><p>Obesity, a global health crisis, has reached epidemic levels, characterized by excessive adipose tissue accumulation and significantly increased risks of chronic diseases, including type 2 diabetes, cardiovascular disease, and certain cancers [<xref rid="B26-pharmaceuticals-18-00150" ref-type="bibr">26</xref>,<xref rid="B27-pharmaceuticals-18-00150" ref-type="bibr">27</xref>]. The escalating prevalence of obesity in both developed and developing countries highlights the urgent need for innovative therapeutic strategies [<xref rid="B28-pharmaceuticals-18-00150" ref-type="bibr">28</xref>]. While lifestyle modifications, including dietary changes and physical activity, remain central to obesity management [<xref rid="B29-pharmaceuticals-18-00150" ref-type="bibr">29</xref>], achieving sustainable weight loss through these methods alone remains challenging for many individuals [<xref rid="B30-pharmaceuticals-18-00150" ref-type="bibr">30</xref>]. Pharmacological interventions provide additional support but often have limited efficacy and are associated with adverse side effects, underscoring the demand for safer and more effective alternatives [<xref rid="B31-pharmaceuticals-18-00150" ref-type="bibr">31</xref>,<xref rid="B32-pharmaceuticals-18-00150" ref-type="bibr">32</xref>].</p><p>Oxidative stress is intricately linked to chronic inflammation and metabolic dysregulation in obesity, positioning antioxidants as essential elements in therapeutic strategies. LSE demonstrated strong antioxidant activity in DPPH and ABTS assays, underscoring its potential to neutralize free radicals and mitigate oxidative damage. This activity is attributed to bioactive compounds such as chlorogenic acid, quercetin-3-<italic toggle="yes">O</italic>-galactoside, and ferulic acid, which are recognized for their potent antioxidant properties [<xref rid="B33-pharmaceuticals-18-00150" ref-type="bibr">33</xref>,<xref rid="B34-pharmaceuticals-18-00150" ref-type="bibr">34</xref>,<xref rid="B35-pharmaceuticals-18-00150" ref-type="bibr">35</xref>]. These effects may reduce oxidative stress in adipose tissue and macrophages, alleviating upstream triggers of chronic inflammation and enhancing LSE&#x02019;s overall therapeutic potential.</p><p>In this study, we evaluated LSE as a dual-action therapeutic agent targeting both adipogenesis and inflammation. LSE significantly enhanced the differentiation and maturation of 3T3-L1 preadipocytes, particularly during the early and intermediate stages of differentiation (<xref rid="pharmaceuticals-18-00150-f001" ref-type="fig">Figure 1</xref> and <xref rid="pharmaceuticals-18-00150-f002" ref-type="fig">Figure 2</xref>). This enhancement was accompanied by the upregulation of key adipogenic and lipogenic genes, including PPAR&#x003b3;, C/EBP&#x003b1;, and FABP4, indicating a regulatory role in adipocyte function. The observed increase in cyclin E expression suggests that LSE may also influence preadipocyte proliferation and mitotic clonal expansion, critical steps in effective adipogenesis. Notably, LSE did not affect CHOP expression, a negative regulator of adipogenesis, implying that it promotes differentiation through CHOP-independent mechanisms (<xref rid="pharmaceuticals-18-00150-f003" ref-type="fig">Figure 3</xref>C,D). This contrasts with findings on Elsholtzia fruticosa (EF), which enhances adipogenesis by downregulating CHOP [<xref rid="B36-pharmaceuticals-18-00150" ref-type="bibr">36</xref>], suggesting that LSE and EF operate via distinct molecular pathways.</p><p>Additionally, this study revealed the potent anti-inflammatory properties of LSE in LPS-stimulated RAW 264.7 macrophages. Chronic, low-grade inflammation is a hallmark of obesity and its complications, including insulin resistance and cardiovascular disease [<xref rid="B37-pharmaceuticals-18-00150" ref-type="bibr">37</xref>]. LSE reduced the expression of pro-inflammatory mediators, such as TNF-&#x003b1;, IL-6, iNOS, and COX-2, and inhibited ERK phosphorylation, demonstrating its potential to attenuate macrophage-mediated inflammation and improve metabolic health (<xref rid="pharmaceuticals-18-00150-f004" ref-type="fig">Figure 4</xref>).</p><p>To better understand the bioactive components of LSE, molecular network modeling and dereplication analyses identified eight major compound groups: glycosides, organic acids, terpenoids, flavonoids, phenylglycosides, phenolics, and fatty acids. Among these, the largest groups of flavonoids, phenolics, and organic acids demonstrated anti-inflammatory benefits by downregulating inflammatory cytokines and mediators [<xref rid="B38-pharmaceuticals-18-00150" ref-type="bibr">38</xref>,<xref rid="B39-pharmaceuticals-18-00150" ref-type="bibr">39</xref>,<xref rid="B40-pharmaceuticals-18-00150" ref-type="bibr">40</xref>]. <xref rid="app1-pharmaceuticals-18-00150" ref-type="app">Figure S2</xref> highlights key compounds detected in the extract (<xref rid="app1-pharmaceuticals-18-00150" ref-type="app">Figure S2, Supplementary Materials</xref>), specifically geshoidin (4), (<italic toggle="yes">S</italic>)-malate (7), 6a,12a-didehydroamorphigenin (18), and 7-methyl-1-[(2<italic toggle="yes">S</italic>,3<italic toggle="yes">R</italic>,4<italic toggle="yes">S</italic>,5<italic toggle="yes">S</italic>,6<italic toggle="yes">R</italic>)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1,5,6,7a-tetrahydrocyclopenta[c]pyran-4a,5,7-triol (19), chlorogenic acid (23), 7-methyl-1-[(2<italic toggle="yes">S</italic>,3<italic toggle="yes">R</italic>,4<italic toggle="yes">S</italic>,5<italic toggle="yes">S</italic>,6<italic toggle="yes">R</italic>)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1,4a,5,6,7,7a-hexahydrocyclopenta[c]pyran-4-carboxylic acid (25), flavovilloside (41), kaempferol 3-<italic toggle="yes">O</italic>-neohesperidoside (56), acteoside (57), quercetin-3-<italic toggle="yes">O</italic>-galactoside (58), ferulic acid (59), (6<italic toggle="yes">R</italic>,9<italic toggle="yes">S</italic>)-3-oxo-&#x003b1;-ionol glucoside (61), quercetin-3-<italic toggle="yes">O</italic>-xyloside (64), (10<italic toggle="yes">E</italic>,15<italic toggle="yes">Z</italic>)-9,12,13-trihydroxyoctadeca-10,15-dienoic acid (85), (<italic toggle="yes">Z</italic>)-9,12,13-trihydroxyoctadec-15-enoic acid (88), 2-(2-acetyloxy-12-hydroxytridecyl)-4,6-dihydroxybenzoic acid (91), forskolin (101), 1-epi coleonol (106), [4,5-dihydroxy-3,4-bis(hydroxymethyl)-4a,8,8-trimethyl-5,6,7,8a-tetrahydro-1H-naphthalen-1-yl] octanoate (108), rotenone (109), and grayanotoxin I (113).</p><p>These compounds are likely contributors to the extract&#x02019;s activity. Prior research confirmed chlorogenic acid, quercetin-3-<italic toggle="yes">O</italic>-galactoside, ferulic acid, quercetin-3-<italic toggle="yes">O</italic>-xyloside, and forskolin significantly reduced TNF-&#x003b1;, IL-6, and other cytokines in LPS-activated macrophages. Chlorogenic acid, quercetin-3-O-galactoside, ferulic acid, quercetin-3-<italic toggle="yes">O</italic>-xyloside, forskolin, and rotenone notably suppressed iNOS and COX-2 protein expression levels [<xref rid="B41-pharmaceuticals-18-00150" ref-type="bibr">41</xref>,<xref rid="B42-pharmaceuticals-18-00150" ref-type="bibr">42</xref>,<xref rid="B43-pharmaceuticals-18-00150" ref-type="bibr">43</xref>,<xref rid="B44-pharmaceuticals-18-00150" ref-type="bibr">44</xref>,<xref rid="B45-pharmaceuticals-18-00150" ref-type="bibr">45</xref>,<xref rid="B46-pharmaceuticals-18-00150" ref-type="bibr">46</xref>].</p><p>LSE also promoted adipocyte differentiation, with chlorogenic acid enhancing the differentiation of 3T3-L1 cells in animal models [<xref rid="B47-pharmaceuticals-18-00150" ref-type="bibr">47</xref>]. Forskolin predominantly upregulated PPAR&#x003b3; and C/EBP&#x003b2; expression [<xref rid="B35-pharmaceuticals-18-00150" ref-type="bibr">35</xref>], while ferulic acid improved inflammation and insulin resistance via the NF&#x003ba;B/MAPK signaling pathways in adipocytes [<xref rid="B48-pharmaceuticals-18-00150" ref-type="bibr">48</xref>]. In silico analyses confirmed that major bioactive compounds interact with key amino acids in the binding pockets of target proteins, displaying varying binding affinities (<xref rid="app1-pharmaceuticals-18-00150" ref-type="app">Figures S4&#x02013;S11, Supplementary Materials</xref>). These interactions likely underpin the biological activities of LSE, offering insights into its mechanisms of action.</p><p>Despite these encouraging findings, this study has limitations. First, the in vitro experiments cannot fully replicate complex in vivo physiological interactions. Future studies using animal models of obesity are necessary to validate the efficacy and safety of LSE in more physiologically relevant conditions. Second, the long-term effects and potential toxicity of LSE remain unexplored and warrant detailed investigation.</p></sec><sec id="sec4-pharmaceuticals-18-00150"><title>4. Materials and Methods</title><sec id="sec4dot1-pharmaceuticals-18-00150"><title>4.1. Methanol Extract of Lagopsis Supina (Stephan Ex Willd.) Ikonn.-Gal</title><p>The <italic toggle="yes">L</italic>. <italic toggle="yes">supina</italic> (Stephan ex Willd.) Ikonn.-Gal. extract (FBM188-007) used in this study was sourced from the International Biological Material Research Center at the Korea Research Institute of Bioscience and Biotechnology (KRIBB, Daejeon, Republic of Korea). The plant, collected in June 2013 from the Bornuur district, Tuv aimag province, Mongolia, is preserved as a voucher specimen (KRIB 0049867) in KRIBB&#x02019;s herbarium. For extraction, 42 g of dried, shade-powdered whole plant and radix materials were immersed in 1 L of 99.9% methanol. The mixture underwent 30 cycles of ultrasonic extraction (SDN-900H, SD-ULTRASONIC CO., LTD., Seoul, Republic of Korea) at room temperature, with each cycle comprising 15 min of ultrasonication (40 kHz, 1500 W) and 120 min of standing. The extract was filtered (No. 100, HYUNDAI MICRO CO., LTD., Seoul, Republic of Korea) and concentrated under reduced pressure, yielding 3.16 g of LSE.</p></sec><sec id="sec4dot2-pharmaceuticals-18-00150"><title>4.2. DPPH and ABTS Assays</title><p>The antioxidant capacity of LSE was assessed through two complementary assays. The DPPH (2,2-diphenyl-1-picrylhydrazyl) free radical scavenging activity was measured at 517 nm using an iMarkTM Microplate Reader (Bio-Rad Laboratories Inc., Hercules, CA, USA), where decreased absorbance indicated increased scavenging activity. ABTS radical scavenging activity was evaluated by measuring absorbance at 743 nm, with reduced absorbance reflecting a lower radical concentration. Ascorbic acid (AA) served as positive control in both assays.</p></sec><sec id="sec4dot3-pharmaceuticals-18-00150"><title>4.3. Cell Culture and Adipocyte Differentiation</title><p>Mouse 3T3-L1 preadipocytes and RAW 264.7 macrophages were procured from the American Type Culture Collection (ATCC, Manassas, VA, USA). 3T3-L1 cells were cultured in Dulbecco&#x02019;s Modified Eagle Medium (DMEM; Welgene, Gyeongsan-si, Republic of Korea) supplemented with 10% bovine calf serum, while RAW 264.7 macrophages were maintained in DMEM containing 10% fetal bovine serum (FBS; Welgene Inc.), 100 U/mL penicillin, and 100 &#x003bc;g/mL streptomycin. All cells were incubated at 37 &#x000b0;C in a humidified atmosphere with 5% CO<sub>2</sub>. For adipocyte differentiation, 3T3-L1 preadipocytes were seeded at 5 &#x000d7; 10<sup>4</sup> cells per well in 12-well plates [<xref rid="B49-pharmaceuticals-18-00150" ref-type="bibr">49</xref>]. Upon reaching confluence (Day 0, D0), the medium was replaced with a differentiation medium comprising DMEM, 10% FBS, and a 0.17 &#x000d7; MDI hormonal cocktail. This cocktail contained 0.17 mM 3-isobutyl-1-methylxanthine (M; Sigma Aldrich, St. Louis, MO, USA), 0.33 &#x003bc;M dexamethasone (D; Sigma Aldrich), and 0.33 &#x003bc;g/mL insulin (I; Sigma Aldrich). To induce terminal differentiation, cells were cultured from Day 2 (D2) onward in DMEM with 10% FBS and 0.2 &#x003bc;g/mL insulin, with the medium refreshed every 48 h until Day 6 (D6). Differentiation into mature adipocytes was verified microscopically by observing rounded cell morphology and intracellular lipid droplets.</p></sec><sec id="sec4dot4-pharmaceuticals-18-00150"><title>4.4. Cell Viability Assay</title><p>Cell viability was evaluated using a WST-8-based cell counting kit (BIOMAX, Seoul, Republic of Korea) per the manufacturer&#x02019;s protocol. This colorimetric assay measures metabolic activity by quantifying the conversion of tetrazolium salt (WST-8) into a water-soluble formazan product by mitochondrial dehydrogenases. In brief, 3T3-L1 and RAW 264.7 cells were seeded into 96-well plates at densities of 1.0 &#x000d7; 10<sup>4</sup> and 1.0 &#x000d7; 10<sup>5</sup> cells/well, respectively, and cultured for 24 h. Cells were then treated with varying concentrations of LSE for 24 h. After treatment, WST-8 reagent was added, and plates were incubated for 1&#x02013;2 h. Absorbance at 450 nm was measured using an iMarkTM Microplate Reader (Bio-Rad Laboratories Inc.), and cell viability was expressed as a percentage relative to untreated controls, set at 100% viability.</p></sec><sec id="sec4dot5-pharmaceuticals-18-00150"><title>4.5. NO Production Assay in RAW 264.7 Cells</title><p>RAW 264.7 macrophages, seeded at 1.0 &#x000d7; 10<sup>5</sup> cells/well in a 96-well plate, were allowed to adhere for 24 h. Upon reaching confluence, cells were treated with different LSE concentrations in DMEM supplemented with 10% FBS without phenol red. Dimethyl sulfoxide (DMSO) was used as a vehicle control, and N-acetylcysteine (NAC, 10 mM) served as a positive control due to its anti-inflammatory effects. After a 2 h pretreatment, lipopolysaccharide (LPS, 0.1 ng/mL) was added to stimulate NO production, followed by 24 h of incubation at 37 &#x000b0;C. Supernatants were collected, centrifuged at 2000 rpm for 10 min at 4 &#x000b0;C, and transferred to new 96-well plates. Equal volumes of supernatant and Griess reagent were mixed (1:1 ratio) following the manufacturer&#x02019;s protocol. Absorbance at 560 nm was measured using an iMark&#x02122; Microplate Reader (Bio-Rad Laboratories Inc.). Nitrite concentration, an indirect marker of NO production, was determined from a standard curve prepared with a commercial NO standard.</p></sec><sec id="sec4dot6-pharmaceuticals-18-00150"><title>4.6. Oil Red O Staining for Lipid Droplets</title><p>Following differentiation, 3T3-L1 adipocytes cultured in 12-well plates were washed twice with Dulbecco&#x02019;s phosphate-buffered saline to remove residual media. The cells were fixed with 3.7% formalin at room temperature for 10 min to maintain cellular morphology. After fixation, they were washed twice with 100% propylene glycol on a shaker at 30 rpm, with each wash lasting 30 min to ensure dehydration. The cells were then stained with 1 mL of 0.7% Oil red O solution for 15 min. Oil red O, a lipophilic dye with a strong affinity for neutral lipids, stained intracellular lipid droplets bright red. Excess dye was removed by a brief wash with 85% propylene glycol for 1 min, followed by thorough rinsing with distilled water. Stained lipid droplets were observed under a microscope (Nexcope NIB410, Ningbo, China) at 200&#x000d7; magnification.</p></sec><sec id="sec4dot7-pharmaceuticals-18-00150"><title>4.7. RNA Isolation and Quantitative Real-Time PCR (qRT-PCR) Analysis</title><p>Total RNA was extracted from cells using the RiboEx&#x02122; reagent (GeneAll Biotechnology, Seoul, Republic of Korea), and complementary DNA (cDNA) was synthesized from the isolated RNA with the ReverTra Ace&#x02122; qPCR RT kit (Toyobo, Osaka, Japan) following the manufacturer&#x02019;s instructions. Gene expression levels were quantified by quantitative real-time PCR (qRT-PCR) using the CFX Connect Real-Time PCR System and SFCgreen PCR Master Mix (Biofact, Deajeon, Republic of Korea). Beta-actin and 36B4 were used as internal controls to normalize the expression data. Primer sequences for most target genes were obtained from previous studies [<xref rid="B22-pharmaceuticals-18-00150" ref-type="bibr">22</xref>,<xref rid="B23-pharmaceuticals-18-00150" ref-type="bibr">23</xref>], with the following exceptions: &#x003b2;-actin (F) 5&#x02032;-GGC TGT ATT CCC CTC CAT CG-3&#x02032; and (R) 5&#x02032;-CCA GTT GGT AAC AAT GCC ATG-3&#x02032;; TNF-&#x003b1; (F) 5&#x02032;-CAT CTT CTC AAA ATT CGA GT-3&#x02032; and (R) 5&#x02032;-TGG GAG TAG ACA AGG TAC AA-3&#x02032;; iNOS (F) 5&#x02032;-CTC AGC CCA ACA ATA CAA GAT-3&#x02032; and (R) 5&#x02032;-TGT GGT GAA GAG TGT CAT GCA-3&#x02032;; COX-2 (F) 5&#x02032;-GAA GTC TTT GGT CTG GTG CGT G-3&#x02032; and (R) 5&#x02032;-GTC TGC TGG TTT GGA ATA GTT GC-3&#x02032;; IL-6 (F) 5&#x02032;-TAG TCC TTC CTA CCC CAA TTT CC-3&#x02032; and (R) 5&#x02032;-TTG GTC CTT AGC CAC TCC TTC-3&#x02032;.</p></sec><sec id="sec4dot8-pharmaceuticals-18-00150"><title>4.8. Western Blot Analysis</title><p>Cell lysates were prepared using a mammalian protein extraction reagent containing protease and phosphatase inhibitors (GenDEPOT, Baker, TX, USA). After centrifugation at 13,000 rpm for 15 min at 4 &#x000b0;C, the supernatants were collected. Protein concentrations were determined using the BCA assay kit (Thermo Scientific, Rockford, IL, USA, Cat. No. 23227). Equal amounts of protein were resolved by SDS-PAGE and transferred to polyvinylidene difluoride (PVDF) membranes. The membranes were blocked with 5% BSA in TBST and incubated overnight at 4 &#x000b0;C with primary antibodies targeting the following proteins: PPAR&#x003b3; (Cell Signaling Technology, Danvers, MA, USA, Cat. No. 2443), adiponectin (Thermo Scientific, Cat. No. MA1-054), CHOP (Cell Signaling Technology, Cat. No. 2895), HSP90 (Santa Cruz Biotechnology, Dallas, TX, USA, Cat. No. SC-13119), iNOS (Cell Signaling Technology, Cat. No. 2443), COX-2 (Thermo Scientific, Cat. No. MA1-054), p44/42 MAPK (ERK1/2) (Cell Signaling Technology, Cat. No. 9102), phospho-p44/43 MAPK (ERK1/2) (Cell Signaling Technology, Cat. No. 4370), and &#x003b2;-actin (Santa Cruz Biotechnology, Cat. No. 8432). After washing, membranes were incubated with horseradish peroxidase (HRP)-conjugated secondary antibodies (Bio-Rad Laboratories Inc.) for 1 h at room temperature. Protein bands were visualized using enhanced chemiluminescence (ECL, Bio-Rad Laboratories Inc.) and imaged with the iBright CL1500 imaging system (Thermo Scientific).</p></sec><sec id="sec4dot9-pharmaceuticals-18-00150"><title>4.9. Transfection and Luciferase and &#x003b2;-galactosidase Assay</title><p>Transfection was carried out using LipofectaminTM 3000 (Thermo Fisher Scientific) according to the manufacturer&#x02019;s instructions. For the luciferase reporter assay, cells were cotransfected with the mammalian expression vector pGL3-DR-1-basic as the reporter construct, pCMV-&#x003b2;-galactosidase for normalization of transfection efficiency, and expression vectors for PPAR&#x003b3; and RXR&#x003b1; where applicable. Luciferase and &#x003b2;-galactosidase activities were measured as previously described [<xref rid="B50-pharmaceuticals-18-00150" ref-type="bibr">50</xref>]. Luminescence from luciferase activity was detected using a MicroLumat Plus LB96V luminometer (Berthold Technologies, Bad Wildbad, Germany), and &#x003b2;-galactosidase activity was measured with an Infinite<sup>&#x000ae;</sup> 200 PRO (Tecan, M&#x000e4;nnedorf, Switzerland). Luciferase activity was reported in relative light units and normalized to &#x003b2;-galactosidase activity to control variations in transfection efficiency.</p></sec><sec id="sec4dot10-pharmaceuticals-18-00150"><title>4.10. UPLC-ESI-Orbitrap MS/MS</title><p>The LC-MS/MS analysis was performed using a Vanquish UHPLC system coupled with an Orbitrap Exploris 120 mass spectrometer (Thermo Fisher Scientific, Sunnyvale, CA, USA) [<xref rid="B51-pharmaceuticals-18-00150" ref-type="bibr">51</xref>]. Chromatographic separation was conducted on a Waters Acquity UPLC HSS T3 column (4.6 &#x000d7; 100 mm, 1.8 &#x003bc;m, Waters, Milford, MA, USA) at 40 &#x000b0;C, with a flow rate of 0.2 mL/min and an injection volume of 4 &#x003bc;L. A gradient solvent system was used for mobile phase elution: phase A (water containing 0.1% formic acid) and phase B (ACN, 0.1% formic acid) were applied in the following sequence: 5%&#x02013;15% (B) for 0&#x02013;4 min, 15%&#x02013;35% (B) for 4&#x02013;12 min, 35%&#x02013;45% (B) for 12&#x02013;17 min, 45%&#x02013;100% (B) for 17&#x02013;23 min (held for 3 min), and 100%&#x02013;5% (B) for 1 min before returning to 5% (B) for re-equilibration. Prior to analysis, sample solutions were filtered through a 0.22 &#x003bc;m PTFE membrane (Agilent Technologies, Santa Clara, CA, USA).</p><p>The MS data were acquired using electrospray ionization (ESI) in negative ion mode with the following settings: spray voltage, 3.5 kV; sheath gas (N<sub>2</sub>) &#x0003e; 50%; auxiliary gas (N<sub>2</sub>) &#x0003e; 15%; heater temperature, 350 &#x000b0;C; capillary temperature, 320 &#x000b0;C. In full MS scanning mode, the mass range was m/z 100&#x02013;1500, with a resolution of 120,000, and in-source collision-induced dissociation (in-source CID) was set to 0 eV. For MS/MS scanning, data-dependent MS<sup>2</sup> (dd-MS<sup>2</sup>) was performed with a resolution of 30,000, and high-energy collision-induced dissociation was used in stepped mode (15 eV, 30 eV, 60 eV).</p></sec><sec id="sec4dot11-pharmaceuticals-18-00150"><title>4.11. Molecular Networking</title><p>The molecular network of the LSE was constructed using the Global Natural Products Social Molecular Networking (GNPS) online platform (<uri xlink:href="https://gnps.ucsd.edu">https://gnps.ucsd.edu</uri>, accessed on 15 June 2024) [<xref rid="B1-pharmaceuticals-18-00150" ref-type="bibr">1</xref>]. Briefly, raw data from the UHPLC&#x02212;ESI-MS/MS analysis were converted into mzXML format using the MSConvert tool from ProteoWizard (<uri xlink:href="https://proteowizard.sourceforge.io/">https://proteowizard.sourceforge.io/</uri>, accessed on 12 June 2024). Data processing was carried out using MZmine 3.9.0, following a previously described method [<xref rid="B24-pharmaceuticals-18-00150" ref-type="bibr">24</xref>]. Molecular networks were generated through the GNPS workflow (<uri xlink:href="https://ccms-ucsd.github.io/GNPSDocumentation/">https://ccms-ucsd.github.io/GNPSDocumentation/</uri>, accessed on 15 June 2024, job ID: 4475ce44b79a414ea9cd2a57c737e14b), and the resulting network data were downloaded from GNPS and visualized using Cytoscape 3.9.1 (<uri xlink:href="https://www.cytoscape.org/">https://www.cytoscape.org/</uri>, accessed on 18 June 2024). The composition of compounds was relatively quantitated by accessing the peak intensity of those detected from the chromatograms.</p></sec><sec id="sec4dot12-pharmaceuticals-18-00150"><title>4.12. LC-MS Annotation</title><p>Component identification from the extracts and fractions was performed using open-source software, including GNPS web tools and MS-Dial, alongside public mass spectrometry databases (GNPS, HMDB, LipidMaps, KNApSAcK, and the American Mass Bank). Compound annotations were made by comparing precursor and fragmentation ion spectra with those in public MS/MS databases for spectral matching.</p></sec><sec id="sec4dot13-pharmaceuticals-18-00150"><title>4.13. Molecular Docking Assay</title><p>The crystal structures of target proteins, including antioxidative (1HCK), adiponectin (PDB ID: 6KS0), PPAR&#x003b3; (PDB ID: 4EMA), IL-6 (PDB ID: 1ALU), iNOS (PDB ID: 3E7G), COX-2 (PDB ID: 5IKQ), TNF-&#x003b1; (PDB ID: 2AZ5), and ERK (PDB ID: 6NBS), were retrieved from the RCSB Protein Data Bank (<uri xlink:href="https://www.rcsb.org">https://www.rcsb.org</uri>; accessed 18 July 2024, 23 July 2024, and 25 July 2024). Protein structures were processed using MGL Tools 1.5.6, which involved removing water and heteroatoms, adding polar hydrogens and Kollman charges, and saving the prepared structures in pdbqt format. Compound structures were downloaded from PubChem (<uri xlink:href="https://pubchem.ncbi.nlm.nih.gov">https://pubchem.ncbi.nlm.nih.gov</uri>; accessed 10 July 2024, 15 July 2024, 22 July 2024, and 30 July 2024) in SDF format. Missing structures were manually created using the Avogadro package, and all structures were converted to pdbqt format using the Open Babel program version 2.4.1. Ligands were prepared in MGL Tools 1.5.6 by adding Gasteiger charges. Grid box parameters were defined using PyMol (version 3.1.1), and the Lamarckian genetic algorithm in AutoDock 4.2.6 was applied to find the optimal ligand conformation. The resulting protein&#x02013;ligand complexes were analyzed and visualized using Discovery Studio Visualizer 2021 and PyMol [<xref rid="B52-pharmaceuticals-18-00150" ref-type="bibr">52</xref>].</p></sec><sec id="sec4dot14-pharmaceuticals-18-00150"><title>4.14. Statistical Analysis</title><p>Data are expressed as the mean &#x000b1; standard error of the mean (SEM) to represent the average value and variability within each treatment group. Sample size (<italic toggle="yes">n</italic>) for each experiment is provided for transparency. Statistical analyses were performed using either Microsoft Excel or GraphPad Prism software version 10.4.1. Comparisons between two groups were made using an unpaired, two-tailed Student&#x02019;s <italic toggle="yes">t</italic>-test. For experiments involving multiple treatment groups, one-way analysis of variance was followed by Tukey&#x02019;s post hoc test to identify significant differences between specific groups. Statistical significance was defined as a <italic toggle="yes">p</italic>-value &#x0003c; 0.05.</p></sec></sec><sec sec-type="conclusions" id="sec5-pharmaceuticals-18-00150"><title>5. Conclusions</title><p>This study underscores the therapeutic potential of <italic toggle="yes">Lagopsis supina</italic> (LSE) extract for obesity and related complications. LSE exhibited robust antioxidant activity, promoted adipocyte differentiation via the upregulation of transcription factors like PPAR&#x003b3;, and enhanced lipogenesis through genes such as FABP4 and SCD1. It also demonstrated notable anti-inflammatory effects in LPS-stimulated macrophages by downregulating pro-inflammatory mediators and inhibiting ERK phosphorylation, addressing metabolic dysregulation and inflammation. Chemical analyses revealed bioactive components, including flavonoids and phenolic acids, that were likely responsible for these effects. Molecular docking provided mechanistic insights, highlighting strong interactions between these compounds and key proteins in antioxidant, adipogenic, and inflammatory pathways. However, the in vitro nature of this study emphasizes the need for in vivo validation to confirm efficacy and safety. Further research on LSE&#x02019;s long-term effects, bioavailability, and synergy with existing therapies is crucial to fully harness its therapeutic potential. In conclusion, LSE offers a novel approach to obesity treatment by addressing metabolic and inflammatory factors, positioning it as a promising candidate for clinical applications.</p></sec></body><back><ack><title>Acknowledgments</title><p>The authors sincerely thank Sunchon National University and Mokpo National University.</p></ack><fn-group><fn><p><bold>Disclaimer/Publisher&#x02019;s Note:</bold> The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.</p></fn></fn-group><app-group><app id="app1-pharmaceuticals-18-00150"><title>Supplementary Materials</title><p>The following supporting information can be downloaded at <uri xlink:href="https://www.mdpi.com/article/10.3390/ph18020150/s1">https://www.mdpi.com/article/10.3390/ph18020150/s1</uri>.</p><supplementary-material id="pharmaceuticals-18-00150-s001" position="float" content-type="local-data"><media xlink:href="pharmaceuticals-18-00150-s001.zip"/></supplementary-material></app></app-group><notes><title>Author Contributions</title><p>Conceptualization, S.-S.S., M.L. and J.B.S.; Methodology, J.C., D.D.L., N.R., J.L., T.D. and V.T.; Software, J.C., D.D.L. and N.R.; Validation, J.C., D.D.L., N.R. and J.L.; Formal Analysis, J.C., D.D.L., N.R., J.L., T.D. and V.T.; Investigation, J.C., D.D.L., N.R., J.L., T.D. and V.T.; Resources, B.B. and S.-Y.K.; Data Curation, J.C., D.D.L., N.R. and J.L.; Writing&#x02014;Original Draft Preparation, J.C., D.D.L. and D.S.; Writing&#x02014;Review and Editing, J.C., D.D.L., N.R., D.S., J.L., T.D., V.T., B.B., S.-Y.K., S.-S.S., M.L. and J.B.S.; Visualization, J.C., D.D.L., N.R., J.L., T.D. and V.T.; Supervision, M.L. and J.B.S.; Project Administration, M.L. and J.B.S.; Funding Acquisition, M.L. and J.B.S. All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Institutional Review Board Statement</title><p>Not applicable.</p></notes><notes><title>Informed Consent Statement</title><p>Not applicable.</p></notes><notes notes-type="data-availability"><title>Data Availability Statement</title><p>Data are contained within the article and <xref rid="app1-pharmaceuticals-18-00150" ref-type="app">Supplementary Materials</xref>.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest.</p></notes><ref-list><title>References</title><ref id="B1-pharmaceuticals-18-00150"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kopelman</surname><given-names>P.G.</given-names></name>
</person-group><article-title>Obesity as a medical problem</article-title><source>Nature</source><year>2000</year><volume>404</volume><fpage>635</fpage><lpage>643</lpage><pub-id pub-id-type="doi">10.1038/35007508</pub-id><pub-id pub-id-type="pmid">10766250</pub-id>
</element-citation></ref><ref id="B2-pharmaceuticals-18-00150"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Parvanova</surname><given-names>A.</given-names></name>
<name><surname>Reseghetti</surname><given-names>E.</given-names></name>
<name><surname>Abbate</surname><given-names>M.</given-names></name>
<name><surname>Ruggenenti</surname><given-names>P.</given-names></name>
</person-group><article-title>Mechanisms and treatment of obesity-related hypertension&#x02014;Part 1: Mechanisms</article-title><source>Clin. Kidney J.</source><year>2024</year><volume>17</volume><fpage>sfad282</fpage><pub-id pub-id-type="doi">10.1093/ckj/sfad282</pub-id><pub-id pub-id-type="pmid">38186879</pub-id>
</element-citation></ref><ref id="B3-pharmaceuticals-18-00150"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chen</surname><given-names>K.</given-names></name>
<name><surname>Shen</surname><given-names>Z.</given-names></name>
<name><surname>Gu</surname><given-names>W.</given-names></name>
<name><surname>Lyu</surname><given-names>Z.</given-names></name>
<name><surname>Qi</surname><given-names>X.</given-names></name>
<name><surname>Mu</surname><given-names>Y.</given-names></name>
<name><surname>Ning</surname><given-names>Y.</given-names></name>
</person-group><article-title>Prevalence of obesity and associated complications in China: A cross-sectional, real-world study in 15.8 million adults</article-title><source>Diabetes Obes. Metab.</source><year>2023</year><volume>25</volume><fpage>3390</fpage><lpage>3399</lpage><pub-id pub-id-type="doi">10.1111/dom.15238</pub-id><pub-id pub-id-type="pmid">37589256</pub-id>
</element-citation></ref><ref id="B4-pharmaceuticals-18-00150"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Pi-Sunyer</surname><given-names>X.</given-names></name>
</person-group><article-title>The medical risks of obesity</article-title><source>Postgrad. Med.</source><year>2009</year><volume>121</volume><fpage>21</fpage><lpage>33</lpage><pub-id pub-id-type="doi">10.3810/pgm.2009.11.2074</pub-id><pub-id pub-id-type="pmid">19940414</pub-id>
</element-citation></ref><ref id="B5-pharmaceuticals-18-00150"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Shimobayashi</surname><given-names>M.</given-names></name>
<name><surname>Albert</surname><given-names>V.</given-names></name>
<name><surname>Woelnerhanssen</surname><given-names>B.</given-names></name>
<name><surname>Frei</surname><given-names>I.C.</given-names></name>
<name><surname>Weissenberger</surname><given-names>D.</given-names></name>
<name><surname>Meyer-Gerspach</surname><given-names>A.C.</given-names></name>
<name><surname>Clement</surname><given-names>N.</given-names></name>
<name><surname>Moes</surname><given-names>S.</given-names></name>
<name><surname>Colombi</surname><given-names>M.</given-names></name>
<name><surname>Meier</surname><given-names>J.A.</given-names></name>
</person-group><article-title>Insulin resistance causes inflammation in adipose tissue</article-title><source>J. Clin. Investig.</source><year>2018</year><volume>128</volume><fpage>1538</fpage><lpage>1550</lpage><pub-id pub-id-type="doi">10.1172/JCI96139</pub-id><pub-id pub-id-type="pmid">29528335</pub-id>
</element-citation></ref><ref id="B6-pharmaceuticals-18-00150"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wu</surname><given-names>H.</given-names></name>
<name><surname>Ballantyne</surname><given-names>C.M.</given-names></name>
</person-group><article-title>Metabolic inflammation and insulin resistance in obesity</article-title><source>Circ. Res.</source><year>2020</year><volume>126</volume><fpage>1549</fpage><lpage>1564</lpage><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.119.315896</pub-id><pub-id pub-id-type="pmid">32437299</pub-id>
</element-citation></ref><ref id="B7-pharmaceuticals-18-00150"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Rohm</surname><given-names>T.V.</given-names></name>
<name><surname>Meier</surname><given-names>D.T.</given-names></name>
<name><surname>Olefsky</surname><given-names>J.M.</given-names></name>
<name><surname>Donath</surname><given-names>M.Y.</given-names></name>
</person-group><article-title>Inflammation in obesity, diabetes, and related disorders</article-title><source>Immunity</source><year>2022</year><volume>55</volume><fpage>31</fpage><lpage>55</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2021.12.013</pub-id><pub-id pub-id-type="pmid">35021057</pub-id>
</element-citation></ref><ref id="B8-pharmaceuticals-18-00150"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Fitzgerald</surname><given-names>K.A.</given-names></name>
<name><surname>Kagan</surname><given-names>J.C.</given-names></name>
</person-group><article-title>Toll-like receptors and the control of immunity</article-title><source>Cell</source><year>2020</year><volume>180</volume><fpage>1044</fpage><lpage>1066</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2020.02.041</pub-id><pub-id pub-id-type="pmid">32164908</pub-id>
</element-citation></ref><ref id="B9-pharmaceuticals-18-00150"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Laroux</surname><given-names>F.</given-names></name>
<name><surname>Pavlick</surname><given-names>K.</given-names></name>
<name><surname>Hines</surname><given-names>I.</given-names></name>
<name><surname>Kawachi</surname><given-names>S.</given-names></name>
<name><surname>Harada</surname><given-names>H.</given-names></name>
<name><surname>Bharwani</surname><given-names>S.</given-names></name>
<name><surname>Hoffman</surname><given-names>J.</given-names></name>
<name><surname>Grisham</surname><given-names>M.</given-names></name>
</person-group><article-title>Role of nitric oxide in inflammation</article-title><source>Acta Physiol. Scand.</source><year>2001</year><volume>173</volume><fpage>113</fpage><lpage>118</lpage><pub-id pub-id-type="doi">10.1046/j.1365-201X.2001.00891.x</pub-id><pub-id pub-id-type="pmid">11678733</pub-id>
</element-citation></ref><ref id="B10-pharmaceuticals-18-00150"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kany</surname><given-names>S.</given-names></name>
<name><surname>Vollrath</surname><given-names>J.T.</given-names></name>
<name><surname>Relja</surname><given-names>B.</given-names></name>
</person-group><article-title>Cytokines in inflammatory disease</article-title><source>Int. J. Mol. Sci.</source><year>2019</year><volume>20</volume><elocation-id>6008</elocation-id><pub-id pub-id-type="doi">10.3390/ijms20236008</pub-id><pub-id pub-id-type="pmid">31795299</pub-id>
</element-citation></ref><ref id="B11-pharmaceuticals-18-00150"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhang</surname><given-names>J.</given-names></name>
<name><surname>Huang</surname><given-names>Z.</given-names></name>
<name><surname>Huo</surname><given-names>H.-X.</given-names></name>
<name><surname>Li</surname><given-names>Y.-T.</given-names></name>
<name><surname>Pang</surname><given-names>D.-R.</given-names></name>
<name><surname>Zheng</surname><given-names>J.</given-names></name>
<name><surname>Zhang</surname><given-names>Q.</given-names></name>
<name><surname>Zhao</surname><given-names>Y.-F.</given-names></name>
<name><surname>Tu</surname><given-names>P.-F.</given-names></name>
<name><surname>Li</surname><given-names>J.</given-names></name>
</person-group><article-title>Chemical constituents from <italic toggle="yes">Lagopsis supina</italic> (steph.) Ik.-Gal. Ex knorr</article-title><source>Biochem. Syst. Ecol.</source><year>2015</year><volume>61</volume><fpage>424</fpage><lpage>428</lpage><pub-id pub-id-type="doi">10.1016/j.bse.2015.07.010</pub-id></element-citation></ref><ref id="B12-pharmaceuticals-18-00150"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Li</surname><given-names>H.</given-names></name>
<name><surname>Li</surname><given-names>M.-M.</given-names></name>
<name><surname>Su</surname><given-names>X.-Q.</given-names></name>
<name><surname>Sun</surname><given-names>J.</given-names></name>
<name><surname>Gu</surname><given-names>Y.-F.</given-names></name>
<name><surname>Zeng</surname><given-names>K.-W.</given-names></name>
<name><surname>Zhang</surname><given-names>Q.</given-names></name>
<name><surname>Zhao</surname><given-names>Y.-F.</given-names></name>
<name><surname>Ferreira</surname><given-names>D.</given-names></name>
<name><surname>Zjawiony</surname><given-names>J.K.</given-names></name>
</person-group><article-title>Anti-inflammatory labdane diterpenoids from <italic toggle="yes">Lagopsis supina</italic></article-title><source>J. Nat. Prod.</source><year>2014</year><volume>77</volume><fpage>1047</fpage><lpage>1053</lpage><pub-id pub-id-type="doi">10.1021/np5001329</pub-id><pub-id pub-id-type="pmid">24707938</pub-id>
</element-citation></ref><ref id="B13-pharmaceuticals-18-00150"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yang</surname><given-names>L.</given-names></name>
<name><surname>Zeng</surname><given-names>H.</given-names></name>
<name><surname>Xia</surname><given-names>X.</given-names></name>
<name><surname>Wang</surname><given-names>H.</given-names></name>
<name><surname>Zhao</surname><given-names>B.</given-names></name>
<name><surname>He</surname><given-names>J.</given-names></name>
</person-group><article-title>Natural phenylethanoid glycosides diuretics derived from <italic toggle="yes">Lagopsis supina</italic>: Biological activity, mechanism, molecular docking, and structure-activity relationship</article-title><source>Bioorg. Chem.</source><year>2022</year><volume>129</volume><elocation-id>106165</elocation-id><pub-id pub-id-type="doi">10.1016/j.bioorg.2022.106165</pub-id><pub-id pub-id-type="pmid">36155092</pub-id>
</element-citation></ref><ref id="B14-pharmaceuticals-18-00150"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bai</surname><given-names>M.</given-names></name>
<name><surname>Liu</surname><given-names>Y.-Y.</given-names></name>
<name><surname>Li</surname><given-names>Y.-L.</given-names></name>
<name><surname>Shi</surname><given-names>W.-Y.</given-names></name>
<name><surname>Li</surname><given-names>K.-X.</given-names></name>
<name><surname>Lu</surname><given-names>L.-W.</given-names></name>
<name><surname>Zhou</surname><given-names>L.</given-names></name>
<name><surname>Lin</surname><given-names>B.</given-names></name>
<name><surname>Huang</surname><given-names>X.-X.</given-names></name>
<name><surname>Song</surname><given-names>S.-J.</given-names></name>
</person-group><article-title>Meroterpenoids and sesquiterpene dimers from <italic toggle="yes">Sarcandra glabra</italic> with anti-neuroinflammatory activity</article-title><source>Ind. Crops Prod.</source><year>2022</year><volume>183</volume><fpage>114983</fpage><pub-id pub-id-type="doi">10.1016/j.indcrop.2022.114983</pub-id></element-citation></ref><ref id="B15-pharmaceuticals-18-00150"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>He</surname><given-names>J.</given-names></name>
<name><surname>Zeng</surname><given-names>L.</given-names></name>
<name><surname>Wei</surname><given-names>R.</given-names></name>
<name><surname>Zhong</surname><given-names>G.</given-names></name>
<name><surname>Zhu</surname><given-names>Y.</given-names></name>
<name><surname>Xu</surname><given-names>T.</given-names></name>
<name><surname>Yang</surname><given-names>L.</given-names></name>
</person-group><article-title><italic toggle="yes">Lagopsis supina</italic> exerts its diuretic effect via inhibition of aquaporin-1, 2 and 3 expression in a rat model of traumatic blood stasis</article-title><source>J. Ethnopharmacol.</source><year>2019</year><volume>231</volume><fpage>446</fpage><lpage>452</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2018.10.034</pub-id><pub-id pub-id-type="pmid">30394291</pub-id>
</element-citation></ref><ref id="B16-pharmaceuticals-18-00150"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>He</surname><given-names>J.</given-names></name>
<name><surname>Zhang</surname><given-names>Q.</given-names></name>
<name><surname>Xia</surname><given-names>X.</given-names></name>
<name><surname>Yang</surname><given-names>L.</given-names></name>
</person-group><article-title><italic toggle="yes">Lagopsis supina</italic> ameliorates myocardial ischemia injury by regulating angiogenesis, thrombosis, inflammation, and energy metabolism through VEGF, ROS and HMGB1 signaling pathways in rats</article-title><source>Phytomedicine</source><year>2023</year><volume>120</volume><fpage>155050</fpage><pub-id pub-id-type="doi">10.1016/j.phymed.2023.155050</pub-id><pub-id pub-id-type="pmid">37708818</pub-id>
</element-citation></ref><ref id="B17-pharmaceuticals-18-00150"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Liu</surname><given-names>Z.</given-names></name>
<name><surname>Yang</surname><given-names>L.</given-names></name>
<name><surname>Li</surname><given-names>L.</given-names></name>
<name><surname>Wei</surname><given-names>R.</given-names></name>
<name><surname>Luo</surname><given-names>X.</given-names></name>
<name><surname>Xu</surname><given-names>T.</given-names></name>
<name><surname>Huang</surname><given-names>Y.</given-names></name>
<name><surname>Mu</surname><given-names>Z.</given-names></name>
<name><surname>He</surname><given-names>J.</given-names></name>
</person-group><article-title>Diuretic and antidiuretic activities of ethanol extract and fractions of <italic toggle="yes">Lagopsis supina</italic> in normal rats</article-title><source>Biomed. Res. Int.</source><year>2019</year><volume>2019</volume><elocation-id>6927374</elocation-id><pub-id pub-id-type="doi">10.1155/2019/6927374</pub-id><pub-id pub-id-type="pmid">31886241</pub-id>
</element-citation></ref><ref id="B18-pharmaceuticals-18-00150"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhang</surname><given-names>J.</given-names></name>
<name><surname>Pang</surname><given-names>D.</given-names></name>
<name><surname>Huang</surname><given-names>Z.</given-names></name>
<name><surname>Huo</surname><given-names>H.</given-names></name>
<name><surname>Li</surname><given-names>Y.</given-names></name>
<name><surname>Zheng</surname><given-names>J.</given-names></name>
<name><surname>Zhang</surname><given-names>Q.</given-names></name>
<name><surname>Zhao</surname><given-names>Y.</given-names></name>
<name><surname>Tu</surname><given-names>P.</given-names></name>
<name><surname>Li</surname><given-names>J.</given-names></name>
</person-group><article-title>Flavonoids from whole plants of <italic toggle="yes">Lagopsis supina</italic></article-title><source>Zhongguo Zhong Yao Za Zhi</source><year>2015</year><volume>40</volume><fpage>3224</fpage><lpage>3228</lpage><pub-id pub-id-type="pmid">26790297</pub-id>
</element-citation></ref><ref id="B19-pharmaceuticals-18-00150"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yang</surname><given-names>L.</given-names></name>
<name><surname>He</surname><given-names>Z.-W.</given-names></name>
<name><surname>He</surname><given-names>J.-W.</given-names></name>
</person-group><article-title>The chemical profiling of aqueous soluble fraction from <italic toggle="yes">Lagopsis supina</italic> and its diuretic effects via suppression of AQP and RAAS pathways in saline-loaded rats</article-title><source>J. Ethnopharmacol.</source><year>2021</year><volume>272</volume><fpage>113951</fpage><pub-id pub-id-type="doi">10.1016/j.jep.2021.113951</pub-id><pub-id pub-id-type="pmid">33610702</pub-id>
</element-citation></ref><ref id="B20-pharmaceuticals-18-00150"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kim</surname><given-names>S.H.</given-names></name>
<name><surname>Kim</surname><given-names>J.</given-names></name>
<name><surname>Sharma</surname><given-names>R.P.</given-names></name>
</person-group><article-title>Inhibition of p38 and ERK MAP kinases blocks endotoxin-induced nitric oxide production and differentially modulates cytokine expression</article-title><source>Pharmacol. Res.</source><year>2004</year><volume>49</volume><fpage>433</fpage><lpage>439</lpage><pub-id pub-id-type="doi">10.1016/j.phrs.2003.11.004</pub-id><pub-id pub-id-type="pmid">14998552</pub-id>
</element-citation></ref><ref id="B21-pharmaceuticals-18-00150"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wang</surname><given-names>K.</given-names></name>
<name><surname>Shi</surname><given-names>J.-T.</given-names></name>
<name><surname>Zhang</surname><given-names>Y.</given-names></name>
<name><surname>Ma</surname><given-names>L.-M.</given-names></name>
<name><surname>Wang</surname><given-names>J.</given-names></name>
<name><surname>Yang</surname><given-names>J.-L.</given-names></name>
</person-group><article-title>Labdane diterpenoids from <italic toggle="yes">Lagopsis supina</italic> and their anti-neuroinflammatory activity</article-title><source>Fitoterapia</source><year>2023</year><volume>169</volume><fpage>105611</fpage><pub-id pub-id-type="doi">10.1016/j.fitote.2023.105611</pub-id><pub-id pub-id-type="pmid">37454779</pub-id>
</element-citation></ref><ref id="B22-pharmaceuticals-18-00150"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yang</surname><given-names>L.</given-names></name>
<name><surname>He</surname><given-names>J.</given-names></name>
</person-group><article-title><italic toggle="yes">Lagopsis supina</italic> extract and its fractions exert prophylactic effects against blood stasis in rats via anti-coagulation, anti-platelet activation and anti-fibrinolysis and chemical characterization by UHPLC-qTOF-MS/MS</article-title><source>Biomed. Pharmacother.</source><year>2020</year><volume>132</volume><elocation-id>110899</elocation-id><pub-id pub-id-type="doi">10.1016/j.biopha.2020.110899</pub-id><pub-id pub-id-type="pmid">33096352</pub-id>
</element-citation></ref><ref id="B23-pharmaceuticals-18-00150"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wang</surname><given-names>W.</given-names></name>
<name><surname>He</surname><given-names>X.</given-names></name>
<name><surname>Ma</surname><given-names>C.</given-names></name>
</person-group><article-title>Metabolism schemes of chlorogenic, quinic and caffeic acid derivatives in rats deduced by molecular fragments detected with optimized UPLC&#x02013;APCI-MS/MS conditions</article-title><source>Int. J. Mass Spectrom.</source><year>2013</year><volume>337</volume><fpage>34</fpage><lpage>42</lpage><pub-id pub-id-type="doi">10.1016/j.ijms.2012.12.015</pub-id></element-citation></ref><ref id="B24-pharmaceuticals-18-00150"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Pikulski</surname><given-names>M.</given-names></name>
<name><surname>Brodbelt</surname><given-names>J.S.</given-names></name>
</person-group><article-title>Differentiation of flavonoid glycoside isomers by using metal complexation and electrospray ionization mass spectrometry</article-title><source>J. Am. Soc. Mass Spectrom.</source><year>2003</year><volume>14</volume><fpage>1437</fpage><lpage>1453</lpage><pub-id pub-id-type="doi">10.1016/j.jasms.2003.07.002</pub-id><pub-id pub-id-type="pmid">14652191</pub-id>
</element-citation></ref><ref id="B25-pharmaceuticals-18-00150"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Pascale</surname><given-names>R.</given-names></name>
<name><surname>Acquavia</surname><given-names>M.A.</given-names></name>
<name><surname>Cataldi</surname><given-names>T.R.I.</given-names></name>
<name><surname>Onzo</surname><given-names>A.</given-names></name>
<name><surname>Coviello</surname><given-names>D.</given-names></name>
<name><surname>Bufo</surname><given-names>S.A.</given-names></name>
<name><surname>Scrano</surname><given-names>L.</given-names></name>
<name><surname>Ciriello</surname><given-names>R.</given-names></name>
<name><surname>Guerrieri</surname><given-names>A.</given-names></name>
<name><surname>Bianco</surname><given-names>G.</given-names></name>
</person-group><article-title>Profiling of quercetin glycosides and acyl glycosides in sun-dried peperoni di Senise peppers (<italic toggle="yes">Capsicum annuum</italic> L.) by a combination of LC-ESI(-)-MS/MS and polarity prediction in reversed-phase separations</article-title><source>Anal. Bioanal. Chem.</source><year>2020</year><volume>412</volume><fpage>3005</fpage><lpage>3015</lpage><pub-id pub-id-type="doi">10.1007/s00216-020-02547-2</pub-id><pub-id pub-id-type="pmid">32215688</pub-id>
</element-citation></ref><ref id="B26-pharmaceuticals-18-00150"><label>26.</label><element-citation publication-type="book"><person-group person-group-type="author">
<name><surname>Haththotuwa</surname><given-names>R.N.</given-names></name>
<name><surname>Wijeyaratne</surname><given-names>C.N.</given-names></name>
<name><surname>Senarath</surname><given-names>U.</given-names></name>
</person-group><article-title>Worldwide epidemic of obesity</article-title><source>Obesity and Obstetrics</source><publisher-name>Elsevier</publisher-name><publisher-loc>Amsterdam, The Netherlands</publisher-loc><year>2020</year><fpage>3</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1016/B978-0-12-817921-5.00001-1</pub-id></element-citation></ref><ref id="B27-pharmaceuticals-18-00150"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Scully</surname><given-names>T.</given-names></name>
<name><surname>Ettela</surname><given-names>A.</given-names></name>
<name><surname>LeRoith</surname><given-names>D.</given-names></name>
<name><surname>Gallagher</surname><given-names>E.J.</given-names></name>
</person-group><article-title>Obesity, type 2 diabetes, and cancer risk</article-title><source>Front. Oncol.</source><year>2021</year><volume>10</volume><elocation-id>615375</elocation-id><pub-id pub-id-type="doi">10.3389/fonc.2020.615375</pub-id><pub-id pub-id-type="pmid">33604295</pub-id>
</element-citation></ref><ref id="B28-pharmaceuticals-18-00150"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mohajan</surname><given-names>D.</given-names></name>
<name><surname>Mohajan</surname><given-names>H.K.</given-names></name>
</person-group><article-title>Obesity and its related diseases: A new escalating alarming in global health</article-title><source>J. Innovat. Med. Res.</source><year>2023</year><volume>2</volume><fpage>12</fpage><lpage>23</lpage><pub-id pub-id-type="doi">10.56397/JIMR/2023.03.04</pub-id></element-citation></ref><ref id="B29-pharmaceuticals-18-00150"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wadden</surname><given-names>T.A.</given-names></name>
<name><surname>Tronieri</surname><given-names>J.S.</given-names></name>
<name><surname>Butryn</surname><given-names>M.L.</given-names></name>
</person-group><article-title>Lifestyle modification approaches for the treatment of obesity in adults</article-title><source>Am. Psychol.</source><year>2020</year><volume>75</volume><fpage>235</fpage><pub-id pub-id-type="doi">10.1037/amp0000517</pub-id><pub-id pub-id-type="pmid">32052997</pub-id>
</element-citation></ref><ref id="B30-pharmaceuticals-18-00150"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Barrea</surname><given-names>L.</given-names></name>
<name><surname>Salzano</surname><given-names>C.</given-names></name>
<name><surname>Pugliese</surname><given-names>G.</given-names></name>
<name><surname>Laudisio</surname><given-names>D.</given-names></name>
<name><surname>Frias-Toral</surname><given-names>E.</given-names></name>
<name><surname>Savastano</surname><given-names>S.</given-names></name>
<name><surname>Colao</surname><given-names>A.</given-names></name>
<name><surname>Muscogiuri</surname><given-names>G.</given-names></name>
</person-group><article-title>The challenge of weight loss maintenance in obesity: A review of the evidence on the best strategies available</article-title><source>Int. J. Food Sci. Nutr.</source><year>2022</year><volume>73</volume><fpage>1030</fpage><lpage>1046</lpage><pub-id pub-id-type="doi">10.1080/09637486.2022.2130186</pub-id><pub-id pub-id-type="pmid">36245260</pub-id>
</element-citation></ref><ref id="B31-pharmaceuticals-18-00150"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Williams</surname><given-names>D.M.</given-names></name>
<name><surname>Nawaz</surname><given-names>A.</given-names></name>
<name><surname>Evans</surname><given-names>M.</given-names></name>
</person-group><article-title>Drug therapy in obesity: A review of current and emerging treatments</article-title><source>Diabetes Ther.</source><year>2020</year><volume>11</volume><fpage>1199</fpage><lpage>1216</lpage><pub-id pub-id-type="doi">10.1007/s13300-020-00816-y</pub-id><pub-id pub-id-type="pmid">32297119</pub-id>
</element-citation></ref><ref id="B32-pharmaceuticals-18-00150"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gadde</surname><given-names>K.M.</given-names></name>
<name><surname>Atkins</surname><given-names>K.D.</given-names></name>
</person-group><article-title>The limits and challenges of antiobesity pharmacotherapy</article-title><source>Expert Opin. Pharmacother.</source><year>2020</year><volume>21</volume><fpage>1319</fpage><lpage>1328</lpage><pub-id pub-id-type="doi">10.1080/14656566.2020.1748599</pub-id><pub-id pub-id-type="pmid">32292094</pub-id>
</element-citation></ref><ref id="B33-pharmaceuticals-18-00150"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhao</surname><given-names>H.</given-names></name>
<name><surname>Li</surname><given-names>Z.</given-names></name>
<name><surname>Sun</surname><given-names>Y.</given-names></name>
<name><surname>Yan</surname><given-names>M.</given-names></name>
<name><surname>Wang</surname><given-names>Y.</given-names></name>
<name><surname>Li</surname><given-names>Y.</given-names></name>
<name><surname>Zhang</surname><given-names>Y.</given-names></name>
<name><surname>Zhu</surname><given-names>M.</given-names></name>
</person-group><article-title>Supplementation of chlorogenic acid alleviates the effects of H<sub>2</sub>O<sub>2</sub>-induced oxidative stress on laying performance, egg quality, antioxidant capacity, hepatic inflammation, mitochondrial dysfunction, and lipid accumulation in laying hens</article-title><source>Antioxidants</source><year>2024</year><volume>13</volume><elocation-id>1303</elocation-id><pub-id pub-id-type="doi">10.3390/antiox13111303</pub-id><pub-id pub-id-type="pmid">39594445</pub-id>
</element-citation></ref><ref id="B34-pharmaceuticals-18-00150"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Jang</surname><given-names>E.</given-names></name>
</person-group><article-title>Hyperoside as a potential natural product targeting oxidative stress in liver diseases</article-title><source>Antioxidants</source><year>2022</year><volume>11</volume><elocation-id>1437</elocation-id><pub-id pub-id-type="doi">10.3390/antiox11081437</pub-id><pub-id pub-id-type="pmid">35892639</pub-id>
</element-citation></ref><ref id="B35-pharmaceuticals-18-00150"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chen</surname><given-names>H.Y.</given-names></name>
<name><surname>Liu</surname><given-names>Q.</given-names></name>
<name><surname>Salter</surname><given-names>A.M.</given-names></name>
<name><surname>Lomax</surname><given-names>M.A.</given-names></name>
</person-group><article-title>Synergism between cAMP and PPAR&#x003b3; signalling in the initiation of UCP1 gene expression in HIB1B brown adipocytes</article-title><source>PPAR Res.</source><year>2013</year><volume>2013</volume><fpage>476049</fpage><pub-id pub-id-type="doi">10.1155/2013/476049</pub-id><pub-id pub-id-type="pmid">23554809</pub-id>
</element-citation></ref><ref id="B36-pharmaceuticals-18-00150"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Shrestha</surname><given-names>D.</given-names></name>
<name><surname>Kim</surname><given-names>E.</given-names></name>
<name><surname>Shrestha</surname><given-names>K.K.</given-names></name>
<name><surname>Suh</surname><given-names>S.-S.</given-names></name>
<name><surname>Kim</surname><given-names>S.-H.</given-names></name>
<name><surname>Seo</surname><given-names>J.B.</given-names></name>
</person-group><article-title>Methanol extract of <italic toggle="yes">Elsholtzia fruticosa</italic> promotes 3T3-L1 preadipocyte differentiation</article-title><source>J. Anim. Sci. Technol.</source><year>2024</year><volume>66</volume><fpage>204</fpage><lpage>218</lpage><pub-id pub-id-type="doi">10.5187/jast.2024.e6</pub-id><pub-id pub-id-type="pmid">38618027</pub-id>
</element-citation></ref><ref id="B37-pharmaceuticals-18-00150"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bakkar</surname><given-names>N.-M.Z.</given-names></name>
<name><surname>Dwaib</surname><given-names>H.S.</given-names></name>
<name><surname>Fares</surname><given-names>S.</given-names></name>
<name><surname>Eid</surname><given-names>A.H.</given-names></name>
<name><surname>Al-Dhaheri</surname><given-names>Y.</given-names></name>
<name><surname>El-Yazbi</surname><given-names>A.F.</given-names></name>
</person-group><article-title>Cardiac autonomic neuropathy: A progressive consequence of chronic low-grade inflammation in type 2 diabetes and related metabolic disorders</article-title><source>Int. J. Mol. Sci.</source><year>2020</year><volume>21</volume><elocation-id>9005</elocation-id><pub-id pub-id-type="doi">10.3390/ijms21239005</pub-id><pub-id pub-id-type="pmid">33260799</pub-id>
</element-citation></ref><ref id="B38-pharmaceuticals-18-00150"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Leyva-L&#x000f3;pez</surname><given-names>N.</given-names></name>
<name><surname>Gutierrez-Grijalva</surname><given-names>E.P.</given-names></name>
<name><surname>Ambriz-Perez</surname><given-names>D.L.</given-names></name>
<name><surname>Heredia</surname><given-names>J.B.</given-names></name>
</person-group><article-title>Flavonoids as cytokine modulators: A possible therapy for inflammation-related diseases</article-title><source>Int. J. Mol. Sci.</source><year>2016</year><volume>17</volume><elocation-id>921</elocation-id><pub-id pub-id-type="doi">10.3390/ijms17060921</pub-id><pub-id pub-id-type="pmid">27294919</pub-id>
</element-citation></ref><ref id="B39-pharmaceuticals-18-00150"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ambriz-P&#x000e9;rez</surname><given-names>D.L.</given-names></name>
<name><surname>Leyva-L&#x000f3;pez</surname><given-names>N.</given-names></name>
<name><surname>Gutierrez-Grijalva</surname><given-names>E.P.</given-names></name>
<name><surname>Heredia</surname><given-names>J.B.</given-names></name>
</person-group><article-title>Phenolic compounds: Natural alternative in inflammation treatment. A Review</article-title><source>Cogent Food Agric.</source><year>2016</year><volume>2</volume><fpage>1131412</fpage><pub-id pub-id-type="doi">10.1080/23311932.2015.1131412</pub-id></element-citation></ref><ref id="B40-pharmaceuticals-18-00150"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Grilli</surname><given-names>E.</given-names></name>
<name><surname>Tugnoli</surname><given-names>B.</given-names></name>
<name><surname>Passey</surname><given-names>J.L.</given-names></name>
<name><surname>Stahl</surname><given-names>C.H.</given-names></name>
<name><surname>Piva</surname><given-names>A.</given-names></name>
<name><surname>Moeser</surname><given-names>A.J.</given-names></name>
</person-group><article-title>Impact of dietary organic acids and botanicals on intestinal integrity and inflammation in weaned pigs</article-title><source>BMC Vet. Res.</source><year>2015</year><volume>11</volume><elocation-id>96</elocation-id><pub-id pub-id-type="doi">10.1186/s12917-015-0410-0</pub-id><pub-id pub-id-type="pmid">25889654</pub-id>
</element-citation></ref><ref id="B41-pharmaceuticals-18-00150"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Huang</surname><given-names>J.</given-names></name>
<name><surname>Xie</surname><given-names>M.</given-names></name>
<name><surname>He</surname><given-names>L.</given-names></name>
<name><surname>Song</surname><given-names>X.</given-names></name>
<name><surname>Cao</surname><given-names>T.</given-names></name>
</person-group><article-title>Chlorogenic acid: A review on its mechanisms of anti-inflammation, disease treatment, and related delivery systems</article-title><source>Front. Pharmacol.</source><year>2023</year><volume>14</volume><elocation-id>1218015</elocation-id><pub-id pub-id-type="doi">10.3389/fphar.2023.1218015</pub-id><pub-id pub-id-type="pmid">37781708</pub-id>
</element-citation></ref><ref id="B42-pharmaceuticals-18-00150"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Xue</surname><given-names>J.-C.</given-names></name>
<name><surname>Yuan</surname><given-names>S.</given-names></name>
<name><surname>Meng</surname><given-names>H.</given-names></name>
<name><surname>Hou</surname><given-names>X.-T.</given-names></name>
<name><surname>Li</surname><given-names>J.</given-names></name>
<name><surname>Zhang</surname><given-names>H.-M.</given-names></name>
<name><surname>Chen</surname><given-names>L.-L.</given-names></name>
<name><surname>Zhang</surname><given-names>C.-H.</given-names></name>
<name><surname>Zhang</surname><given-names>Q.-G.</given-names></name>
</person-group><article-title>The role and mechanism of flavonoid herbal natural products in ulcerative colitis</article-title><source>Biomed. Pharmacother.</source><year>2023</year><volume>158</volume><elocation-id>114086</elocation-id><pub-id pub-id-type="doi">10.1016/j.biopha.2022.114086</pub-id><pub-id pub-id-type="pmid">36502751</pub-id>
</element-citation></ref><ref id="B43-pharmaceuticals-18-00150"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Adeyi</surname><given-names>O.E.</given-names></name>
<name><surname>Somade</surname><given-names>O.T.</given-names></name>
<name><surname>Ajayi</surname><given-names>B.O.</given-names></name>
<name><surname>James</surname><given-names>A.S.</given-names></name>
<name><surname>Adeboye</surname><given-names>T.R.</given-names></name>
<name><surname>Olufemi</surname><given-names>D.A.</given-names></name>
<name><surname>Oyinlola</surname><given-names>E.V.</given-names></name>
<name><surname>Sanyaolu</surname><given-names>E.T.</given-names></name>
<name><surname>Mufutau</surname><given-names>I.O.</given-names></name>
</person-group><article-title>The anti-inflammatory effect of ferulic acid is via the modulation of NF&#x003ba;B-TNF-&#x003b1;-IL-6 and STAT1-PIAS1 signaling pathways in 2-methoxyethanol-induced testicular inflammation in rats</article-title><source>Phytomed. Plus</source><year>2023</year><volume>3</volume><fpage>100464</fpage><pub-id pub-id-type="doi">10.1016/j.phyplu.2023.100464</pub-id></element-citation></ref><ref id="B44-pharmaceuticals-18-00150"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lee</surname><given-names>J.</given-names></name>
<name><surname>Choi</surname><given-names>J.W.</given-names></name>
<name><surname>Sohng</surname><given-names>J.K.</given-names></name>
<name><surname>Pandey</surname><given-names>R.P.</given-names></name>
<name><surname>Park</surname><given-names>Y.I.</given-names></name>
</person-group><article-title>The immunostimulating activity of quercetin 3-<italic toggle="yes">O</italic>-xyloside in murine macrophages via activation of the ASK1/MAPK/NF-&#x003ba;B signaling pathway</article-title><source>Int. Immunopharmacol.</source><year>2016</year><volume>31</volume><fpage>88</fpage><lpage>97</lpage><pub-id pub-id-type="doi">10.1016/j.intimp.2015.12.008</pub-id><pub-id pub-id-type="pmid">26709074</pub-id>
</element-citation></ref><ref id="B45-pharmaceuticals-18-00150"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Krishnamoorthy</surname><given-names>K.</given-names></name>
<name><surname>Senguttuvan</surname><given-names>J.</given-names></name>
</person-group><article-title>Evaluation of anti-inflammatory and antioxidant properties of crude extract and forskolin from <italic toggle="yes">Solena amplexicaulis</italic> Leaf</article-title><source>Indian J. Pharm. Sci.</source><year>2016</year><volume>78</volume><fpage>377</fpage><lpage>387</lpage><pub-id pub-id-type="doi">10.4172/pharmaceutical-sciences.1000128</pub-id></element-citation></ref><ref id="B46-pharmaceuticals-18-00150"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bombicino</surname><given-names>S.S.</given-names></name>
<name><surname>Iglesias</surname><given-names>D.E.</given-names></name>
<name><surname>Zaobornyj</surname><given-names>T.</given-names></name>
<name><surname>Boveris</surname><given-names>A.</given-names></name>
<name><surname>Valdez</surname><given-names>L.B.</given-names></name>
</person-group><article-title>Mitochondrial nitric oxide production supported by reverse electron transfer</article-title><source>Arch. Biochem. Biophys.</source><year>2016</year><volume>607</volume><fpage>8</fpage><lpage>19</lpage><pub-id pub-id-type="doi">10.1016/j.abb.2016.08.010</pub-id><pub-id pub-id-type="pmid">27523732</pub-id>
</element-citation></ref><ref id="B47-pharmaceuticals-18-00150"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Peng</surname><given-names>S.-g.</given-names></name>
<name><surname>Pang</surname><given-names>Y.-l.</given-names></name>
<name><surname>Zhu</surname><given-names>Q.</given-names></name>
<name><surname>Kang</surname><given-names>J.-h.</given-names></name>
<name><surname>Liu</surname><given-names>M.-x.</given-names></name>
<name><surname>Wang</surname><given-names>Z.</given-names></name>
</person-group><article-title>Chlorogenic acid functions as a novel agonist of PPAR&#x003b3;2 during the differentiation of mouse 3T3-L1 preadipocytes</article-title><source>BioMed. Res. Int.</source><year>2018</year><volume>2018</volume><elocation-id>8594767</elocation-id><pub-id pub-id-type="doi">10.1155/2018/8594767</pub-id><pub-id pub-id-type="pmid">30627576</pub-id>
</element-citation></ref><ref id="B48-pharmaceuticals-18-00150"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Park</surname><given-names>J.-E.</given-names></name>
<name><surname>Han</surname><given-names>J.-S.</given-names></name>
</person-group><article-title>Improving the effect of ferulic acid on inflammation and insulin resistance by regulating the JNK/ERK and NF-&#x003ba;B pathways in TNF-&#x003b1;-treated 3T3-L1 adipocytes</article-title><source>Nutrients</source><year>2024</year><volume>16</volume><elocation-id>294</elocation-id><pub-id pub-id-type="doi">10.3390/nu16020294</pub-id><pub-id pub-id-type="pmid">38257186</pub-id>
</element-citation></ref><ref id="B49-pharmaceuticals-18-00150"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yeon</surname><given-names>J.</given-names></name>
<name><surname>Kim</surname><given-names>E.</given-names></name>
<name><surname>Bazarragchaa</surname><given-names>B.</given-names></name>
<name><surname>Kim</surname><given-names>S.-Y.</given-names></name>
<name><surname>Huh</surname><given-names>J.Y.</given-names></name>
<name><surname>Park</surname><given-names>H.</given-names></name>
<name><surname>Suh</surname><given-names>S.-S.</given-names></name>
<name><surname>Seo</surname><given-names>J.B.</given-names></name>
</person-group><article-title><italic toggle="yes">Stellera chamaejasme</italic> L. extract inhibits adipocyte differentiation through activation of the extracellular signal-regulated kinase pathway</article-title><source>PLoS ONE</source><year>2024</year><volume>19</volume><elocation-id>e0300520</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0300520</pub-id><pub-id pub-id-type="pmid">38512891</pub-id>
</element-citation></ref><ref id="B50-pharmaceuticals-18-00150"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Le</surname><given-names>D.D.</given-names></name>
<name><surname>Kim</surname><given-names>E.</given-names></name>
<name><surname>Dang</surname><given-names>T.</given-names></name>
<name><surname>Lee</surname><given-names>J.</given-names></name>
<name><surname>Shin</surname><given-names>C.H.</given-names></name>
<name><surname>Park</surname><given-names>J.W.</given-names></name>
<name><surname>Lee</surname><given-names>S.-g.</given-names></name>
<name><surname>Seo</surname><given-names>J.B.</given-names></name>
<name><surname>Lee</surname><given-names>M.</given-names></name>
</person-group><article-title>Chemical investigation and regulation of adipogenic differentiation of cultivated <italic toggle="yes">Moringa oleifera</italic></article-title><source>Pharmaceuticals</source><year>2024</year><volume>17</volume><elocation-id>1310</elocation-id><pub-id pub-id-type="doi">10.3390/ph17101310</pub-id><pub-id pub-id-type="pmid">39458951</pub-id>
</element-citation></ref><ref id="B51-pharmaceuticals-18-00150"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Le</surname><given-names>D.D.</given-names></name>
<name><surname>Kim</surname><given-names>Y.-R.</given-names></name>
<name><surname>Yu</surname><given-names>S.</given-names></name>
<name><surname>Dang</surname><given-names>T.</given-names></name>
<name><surname>Lee</surname><given-names>K.-T.</given-names></name>
<name><surname>Lee</surname><given-names>M.</given-names></name>
</person-group><article-title>Phytochemical and bioactivities of promising flavonoid glycosides and their content from unmatured fruits of <italic toggle="yes">Vicia bungei</italic> with their bioactivity</article-title><source>Food Chem.</source><year>2024</year><volume>460</volume><fpage>140541</fpage><pub-id pub-id-type="doi">10.1016/j.foodchem.2024.140541</pub-id><pub-id pub-id-type="pmid">39137573</pub-id>
</element-citation></ref><ref id="B52-pharmaceuticals-18-00150"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Le</surname><given-names>D.D.</given-names></name>
<name><surname>Jang</surname><given-names>Y.S.</given-names></name>
<name><surname>Truong</surname><given-names>V.</given-names></name>
<name><surname>Yu</surname><given-names>S.</given-names></name>
<name><surname>Dinh</surname><given-names>T.</given-names></name>
<name><surname>Lee</surname><given-names>M.</given-names></name>
</person-group><article-title>Bioactivities of quinic acids from <italic toggle="yes">Vitex rotundifolia</italic> obtained by supercritical fluid extraction</article-title><source>Antioxidants</source><year>2024</year><volume>13</volume><elocation-id>1235</elocation-id><pub-id pub-id-type="doi">10.3390/antiox13101235</pub-id><pub-id pub-id-type="pmid">39456488</pub-id>
</element-citation></ref></ref-list></back><floats-group><fig position="float" id="pharmaceuticals-18-00150-f001"><label>Figure 1</label><caption><p>Antioxidant activities of <italic toggle="yes">Lagopsis supina</italic> extract (LSE): The radical scavenging activity of DPPH (<bold>A</bold>) and ABTS (<bold>B</bold>) was assessed at varying concentrations of LSE. Results are presented as mean &#x000b1; SEM (<italic toggle="yes">n</italic> = 3). Ascorbic acid (AA, 150 &#x000b5;g/mL) served as positive control. Adipogenesis and lipogenic gene expression induced by LSE: Effects of LSE on adipogenesis were studied in 3T3-L1 cells differentiated using induction medium containing 0.17 &#x000d7; IBMX, dexamethasone, and insulin (DMI). Cells were treated with LSE (30, 50, 100 &#x000b5;g/mL), a control treatment, or rosiglitazone (10 &#x000b5;M) as a positive control. (<bold>C</bold>) Oil red O staining visualized intracellular lipid accumulation; the scale bar represents 100 &#x000b5;m at 200&#x000d7; magnification. (<bold>D</bold>) Quantitative real-time PCR (qRT-PCR) analyzed adipogenesis-related gene expression, including PPAR&#x003b3;, C/EBP&#x003b1;, C/EBP&#x003b2;, FABP4, and adiponectin. (<bold>E</bold>) Western blot analysis evaluated protein levels of PPAR&#x003b3; and adiponectin, with HSP90 used as a loading control. (<bold>F</bold>) qRT-PCR quantified mRNA levels of lipogenesis-associated genes such as SCD1, SCD2, FAS, and ACC. Data are shown as mean &#x000b1; SEM from two independent experiments (<italic toggle="yes">n</italic> = 4). Statistical significance relative to the control group is denoted as * <italic toggle="yes">p</italic> &#x0003c; 0.05, ** <italic toggle="yes">p</italic> &#x0003c; 0.01, and *** <italic toggle="yes">p</italic> &#x0003c; 0.001.</p></caption><graphic xlink:href="pharmaceuticals-18-00150-g001" position="float"/></fig><fig position="float" id="pharmaceuticals-18-00150-f002"><label>Figure 2</label><caption><p>Time-dependent effects of LSE on adipocyte differentiation: (<bold>A</bold>) A schematic diagram illustrates the experimental design, where 3T3-L1 cells were treated with 100 &#x000b5;g/mL LSE for different durations (Groups 1&#x02013;7), starting 2 days after reaching confluence. (<bold>B</bold>) Oil red O staining visualized intracellular lipid accumulation after 6 days of treatment. The scale bar represents 100 &#x000b5;m at 200&#x000d7; magnification. (<bold>C</bold>) On Day 6, total RNA was extracted, and qRT-PCR analyzed mRNA levels of adipogenesis-related genes, including PPAR&#x003b3;, C/EBP&#x003b1;, C/EBP&#x003b2;, FABP4, and Adiponectin. (<bold>D</bold>) Western blotting evaluated protein levels of PPAR&#x003b3; and Adiponectin, using HSP90 as a loading control. (<bold>E</bold>) qRT-PCR quantified mRNA expression of lipogenesis-related genes, including SCD1, SCD2, FAS, and ACC. Data are presented as mean &#x000b1; SEM from two independent experiments. Statistical significance relative to the control group is denoted as * <italic toggle="yes">p</italic> &#x0003c; 0.05, ** <italic toggle="yes">p</italic> &#x0003c; 0.01, and *** <italic toggle="yes">p</italic> &#x0003c; 0.001.</p></caption><graphic xlink:href="pharmaceuticals-18-00150-g002" position="float"/></fig><fig position="float" id="pharmaceuticals-18-00150-f003"><label>Figure 3</label><caption><p>Effects of LSE on early adipogenesis and cell cycle regulation: 3T3-L1 cells were cultured to confluence over 48 h, followed by treatment with 100 &#x003bc;g/mL LSE. (<bold>A</bold>) qRT-PCR analyzed mRNA levels of adipogenesis-related genes, including PPAR&#x003b3;, C/EBP&#x003b1;, and C/EBP&#x003b2;. (<bold>B</bold>) mRNA levels of cell cycle-related genes Cyclin E and CDK2 were quantified using qRT-PCR. (<bold>C</bold>) CHOP mRNA levels were assessed via qRT-PCR, and (<bold>D</bold>) protein expression of CHOP, a cellular stress response marker, was analyzed by Western blotting. (<bold>E</bold>) LSE&#x02019;s effect on PPAR&#x003b3; activity was determined by transfecting h293a cells with DR-1-Luc containing PPRE sequences upstream of a luciferase gene; cells were treated with LSE (30 and 100 &#x003bc;g/mL) or rosiglitazone (10 &#x003bc;M) for 24 h, and luminescence levels were normalized to &#x003b2;-gal assay O.D. values. (<bold>F</bold>) The effect of LSE on PPAR&#x003b3; target gene expression was examined by treating differentiated adipocytes with 100 &#x003bc;g/mL LSE, 10 &#x003bc;M rosiglitazone (positive control), or DMSO (negative control) for 2 days, followed by qRT-PCR analysis. Data represent mean &#x000b1; SEM from two independent experiments. Statistical significance is denoted as * <italic toggle="yes">p</italic> &#x0003c; 0.05, ** <italic toggle="yes">p</italic> &#x0003c; 0.01, and *** <italic toggle="yes">p</italic> &#x0003c; 0.001; <sup>###</sup>
<italic toggle="yes">p</italic> &#x0003c; 0.001 compared to DR-Luc Reporter/PPAR&#x003b3;/RXR&#x003b1; -transfected cells; NS = not significant.</p></caption><graphic xlink:href="pharmaceuticals-18-00150-g003" position="float"/></fig><fig position="float" id="pharmaceuticals-18-00150-f004"><label>Figure 4</label><caption><p>Effects of <italic toggle="yes">Lagopsis supina</italic> extract (LSE) on RAW 264.7 cell viability and lipopolysaccharide (LPS)-induced inflammation: (<bold>A</bold>) RAW 264.7 macrophages were treated with varying concentrations of LSE for 24 h, and cell viability was assessed using a WST-8 assay. Results are expressed as a percentage relative to the control group (<italic toggle="yes">n</italic> = 5). (<bold>B</bold>) RAW 264.7 macrophages were pre-treated with LSE for 2 h, followed by LPS stimulation for 24 h. Nitric oxide (NO) production was quantified using the Griess reaction assay, with N-acetylcysteine (NAC) as a positive control. Data represents mean &#x000b1; SEM from two independent experiments (<italic toggle="yes">n</italic> = 4). &#x0201c;ns&#x0201d; denotes no significant difference from the control group. (<bold>C</bold>) qRT-PCR analyzed mRNA levels of inflammatory genes, including iNOS, COX-2, TNF-&#x003b1;, and IL-6, with NAC serving as a positive control. (<bold>D</bold>) Western blot analysis evaluated protein levels of iNOS and COX-2, with NAC as a positive control. Data represent mean &#x000b1; SEM from two independent experiments (<italic toggle="yes">n</italic> = 4 for each condition). (<bold>E</bold>) RAW 264.7 macrophages were pre-treated with LSE (30, 100, and 300 &#x003bc;g/mL) for 2 h, followed by LPS stimulation for 24 h. Western blot analysis examined the expression of ERK and its phosphorylated form (p-ERK). NAC was used as positive control. ERK denotes extracellular signal-regulated kinase, and p-ERK refers to its phosphorylated form. Statistical significance is indicated as follows: *** <italic toggle="yes">p</italic> &#x0003c; 0.001, ** <italic toggle="yes">p</italic> &#x0003c; 0.01, * <italic toggle="yes">p</italic> &#x0003c; 0.05 compared to unstimulated control cells; <sup>#</sup>
<italic toggle="yes">p</italic> &#x0003c; 0.05, <sup>##</sup>
<italic toggle="yes">p</italic> &#x0003c; 0.01, <sup>###</sup>
<italic toggle="yes">p</italic> &#x0003c; 0.001 compared to LPS-stimulated cells; NS = not significant.</p></caption><graphic xlink:href="pharmaceuticals-18-00150-g004" position="float"/></fig><fig position="float" id="pharmaceuticals-18-00150-f005"><label>Figure 5</label><caption><p>Feature-based molecular network of LSE and specific clusters (A, D, M, J, and X).</p></caption><graphic xlink:href="pharmaceuticals-18-00150-g005" position="float"/></fig><fig position="float" id="pharmaceuticals-18-00150-f006"><label>Figure 6</label><caption><p>Interactions of compounds 55 (Raspberry), 57 (Green), 85 (Limon), 88 (Blue), 91 (Purple blue), 101 (Wheat), 106 (Magenta), 108 (Cyan), 109 (Orange), and 113 (Gray) with amino acid when they were docked into target protein (PDB ID 1HCK).</p></caption><graphic xlink:href="pharmaceuticals-18-00150-g006" position="float"/></fig><fig position="float" id="pharmaceuticals-18-00150-f007"><label>Figure 7</label><caption><p>Interactions of compounds 55 (Raspberry), 57 (Green), 85 (Limon), 88 (Blue), 91 (Purple blue), 101 (Wheat), 106 (Magenta), 108 (Cyan), 109 (Orange), and 113 (Gray) with amino acid when they were docked into adiponectin protein (PDB ID: 6KS0).</p></caption><graphic xlink:href="pharmaceuticals-18-00150-g007" position="float"/></fig><fig position="float" id="pharmaceuticals-18-00150-f008"><label>Figure 8</label><caption><p>Interactions of compounds 55 (Raspberry), 57 (Green), 85 (Limon), 88 (Blue), 91 (Purple blue), 101 (Wheat), 106 (Magenta), 108 (Cyan), 109 (Orange), and 113 (Gray) with amino acid when they were docked into PPAR&#x003b3; protein (PDB ID: 4EMA).</p></caption><graphic xlink:href="pharmaceuticals-18-00150-g008" position="float"/></fig><fig position="float" id="pharmaceuticals-18-00150-f009"><label>Figure 9</label><caption><p>Interactions of compounds 55 (Raspberry), 57 (Green), 85 (Limon), 88 (Blue), 91 (Purple blue), 101 (Wheat), 106 (Magenta), 108 (Cyan), 109 (Orange), and 113 (Gray) with amino acids when they were docked into iNOS protein (PDB ID 5IKQ).</p></caption><graphic xlink:href="pharmaceuticals-18-00150-g009" position="float"/></fig><fig position="float" id="pharmaceuticals-18-00150-f010"><label>Figure 10</label><caption><p>Interactions of compounds 55 (Raspberry), 57 (Green), 85 (Limon), 88 (Blue), 91 (Purple blue), 101 (Wheat), 106 (Magenta), 108 (Cyan), 109 (Orange), and 113 (Gray) with amino acids when they were docked into COX-2 protein (PDB ID 5IKQ).</p></caption><graphic xlink:href="pharmaceuticals-18-00150-g010" position="float"/></fig><fig position="float" id="pharmaceuticals-18-00150-f011"><label>Figure 11</label><caption><p>Interactions of compounds 55 (Raspberry), 57 (Green), 85 (Limon), 88 (Blue), 91 (Purple blue), 101 (Wheat), 106 (Magenta), 108 (Cyan), 109 (Orange), and 113 (Gray) with amino acids when they were docked into IL-6 protein (PDB ID: 1ALU).</p></caption><graphic xlink:href="pharmaceuticals-18-00150-g011" position="float"/></fig><fig position="float" id="pharmaceuticals-18-00150-f012"><label>Figure 12</label><caption><p>Interactions of compounds 55 (Raspberry), 57 (Green), 88 (Blue), 91 (Purple blue), 101 (Wheat), 106 (Magenta), 108 (Cyan), 109 (Orange), and 113 (Gray) with amino acids when they were docked into TNF-&#x003b1; protein (PDB ID: 2AZ5).</p></caption><graphic xlink:href="pharmaceuticals-18-00150-g012" position="float"/></fig><fig position="float" id="pharmaceuticals-18-00150-f013"><label>Figure 13</label><caption><p>Interactions of compounds 55 (Raspberry), 57 (Green), 85 (Limon), 88 (Blue), 91 (Purple blue), 101 (Wheat), 106 (Magenta), 108 (Cyan), 109 (Orange), and 113 (Gray) with amino acids when they were docked into ERK protein (PDB ID: 6NBS).</p></caption><graphic xlink:href="pharmaceuticals-18-00150-g013" position="float"/></fig><table-wrap position="float" id="pharmaceuticals-18-00150-t001"><object-id pub-id-type="pii">pharmaceuticals-18-00150-t001_Table 1</object-id><label>Table 1</label><caption><p>Identification of metabolites from LSE.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">No.</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Compound</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">RT (min)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Formula</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Adduct</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> (Da)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Error (mDa)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Class</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">Unknown</td><td align="center" valign="middle" rowspan="1" colspan="1">1.080</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">[M-H]<sup>&#x02212;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">386.9382</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">2</td><td align="center" valign="middle" rowspan="1" colspan="1">Unknown</td><td align="center" valign="middle" rowspan="1" colspan="1">1.090</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">[M-H]<sup>&#x02212;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">272.9587</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">3</td><td align="center" valign="middle" rowspan="1" colspan="1">Unknown</td><td align="center" valign="middle" rowspan="1" colspan="1">1.090</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">[M-H]<sup>&#x02212;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">158.9782</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">4</td><td align="center" valign="middle" rowspan="1" colspan="1">Geshoidin</td><td align="center" valign="middle" rowspan="1" colspan="1">1.273</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>18</sub>H<sub>18</sub>O<sub>9</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">[M-H]<sup>&#x02212;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">377.0853</td><td align="center" valign="middle" rowspan="1" colspan="1">2.496</td><td align="center" valign="middle" rowspan="1" colspan="1">Glycosides</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">5</td><td align="center" valign="middle" rowspan="1" colspan="1">Quinic acid <sup>&#x02020;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">1.304</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>7</sub>H<sub>12</sub>O<sub>6</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">[M-H]<sup>&#x02212;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">191.0559</td><td align="center" valign="middle" rowspan="1" colspan="1">0.172</td><td align="center" valign="middle" rowspan="1" colspan="1">Organic acids</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">6</td><td align="center" valign="middle" rowspan="1" colspan="1">Unknown</td><td align="center" valign="middle" rowspan="1" colspan="1">1.310</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">[M-H]<sup>&#x02212;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">404.1040</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">7</td><td align="center" valign="middle" rowspan="1" colspan="1">(<italic toggle="yes">S</italic>)-malate</td><td align="center" valign="middle" rowspan="1" colspan="1">1.342</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>4</sub>H<sub>6</sub>O<sub>5</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">[M-H]<sup>&#x02212;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">133.0140</td><td align="center" valign="middle" rowspan="1" colspan="1">0.168</td><td align="center" valign="middle" rowspan="1" colspan="1">Organic acids</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">8</td><td align="center" valign="middle" rowspan="1" colspan="1">N-Fructosyl pyroglutamate</td><td align="center" valign="middle" rowspan="1" colspan="1">1.349</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>11</sub>H<sub>17</sub>NO<sub>8</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">[M-H]<sup>&#x02212;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">290.0879</td><td align="center" valign="middle" rowspan="1" colspan="1">0.782</td><td align="center" valign="middle" rowspan="1" colspan="1">Organic acids</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">9</td><td align="center" valign="middle" rowspan="1" colspan="1">Sucrose</td><td align="center" valign="middle" rowspan="1" colspan="1">1.379</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>12</sub>H<sub>22</sub>O<sub>11</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">[M-H]<sup>&#x02212;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">341.1083</td><td align="center" valign="middle" rowspan="1" colspan="1">0.651</td><td align="center" valign="middle" rowspan="1" colspan="1">Glycosides</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">10</td><td align="center" valign="middle" rowspan="1" colspan="1">5-Oxo-D-proline</td><td align="center" valign="middle" rowspan="1" colspan="1">1.902</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>5</sub>H<sub>7</sub>NO<sub>3</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">[M-H]<sup>&#x02212;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">128.0352</td><td align="center" valign="middle" rowspan="1" colspan="1">0.103</td><td align="center" valign="middle" rowspan="1" colspan="1">Organic acids</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">11</td><td align="center" valign="middle" rowspan="1" colspan="1">Citrate</td><td align="center" valign="middle" rowspan="1" colspan="1">1.902</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>6</sub>H<sub>8</sub>O<sub>7</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">[M-H]<sup>&#x02212;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">191.0194</td><td align="center" valign="middle" rowspan="1" colspan="1">0.258</td><td align="center" valign="middle" rowspan="1" colspan="1">Organic acids</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">12</td><td align="center" valign="middle" rowspan="1" colspan="1">Succinate</td><td align="center" valign="middle" rowspan="1" colspan="1">2.187</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>4</sub>H<sub>6</sub>O<sub>4</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">[M-H]<sup>&#x02212;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">117.0192</td><td align="center" valign="middle" rowspan="1" colspan="1">0.061</td><td align="center" valign="middle" rowspan="1" colspan="1">Organic acids</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">13</td><td align="center" valign="middle" rowspan="1" colspan="1">5,9-dihydroxy-5,7,7-trimethyl-4,5a,6,8,8a,9-hexahydro-1H-azuleno[5,6-c]furan-3-one</td><td align="center" valign="middle" rowspan="1" colspan="1">2.221</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>15</sub>H<sub>22</sub>O<sub>4</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">[M-H]<sup>&#x02212;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">265.0928</td><td align="center" valign="middle" rowspan="1" colspan="1">1.156</td><td align="center" valign="middle" rowspan="1" colspan="1">Sesquiterpenes</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">14</td><td align="center" valign="middle" rowspan="1" colspan="1">1-<italic toggle="yes">O</italic>-Caffeoylglucose</td><td align="center" valign="middle" rowspan="1" colspan="1">2.221</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>15</sub>H<sub>18</sub>O<sub>9</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">[M-H]<sup>&#x02212;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">341.0873</td><td align="center" valign="middle" rowspan="1" colspan="1">0.295</td><td align="center" valign="middle" rowspan="1" colspan="1">Glycosides</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">15</td><td align="center" valign="middle" rowspan="1" colspan="1">(1<italic toggle="yes">S</italic>,6<italic toggle="yes">S</italic>,13<italic toggle="yes">S</italic>)-13-Hydroxy-16,17-dimethoxy-6-prop-1-en-2-yl-2,7,20-trioxapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-3(11),4(8),9,14,16,18-hexaen-12-one</td><td align="center" valign="middle" rowspan="1" colspan="1">2.327</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>23</sub>H<sub>22</sub>O<sub>7</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">[M-H]<sup>&#x02212;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">409.1349</td><td align="center" valign="middle" rowspan="1" colspan="1">4.917</td><td align="center" valign="middle" rowspan="1" colspan="1">Isoflavonoids</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">16</td><td align="center" valign="middle" rowspan="1" colspan="1">3-(4-Hydroxyphenyl)lactate</td><td align="center" valign="middle" rowspan="1" colspan="1">3.155</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>9</sub>H<sub>10</sub>O<sub>4</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">[M-H]<sup>&#x02212;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">181.0506</td><td align="center" valign="middle" rowspan="1" colspan="1">0.032</td><td align="center" valign="middle" rowspan="1" colspan="1">Organic acids</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">17</td><td align="center" valign="middle" rowspan="1" colspan="1">Unknown</td><td align="center" valign="middle" rowspan="1" colspan="1">3.155</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">[M-H]<sup>&#x02212;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">361.1137</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">18</td><td align="center" valign="middle" rowspan="1" colspan="1">6a,12a-Didehydroamorphigenin</td><td align="center" valign="middle" rowspan="1" colspan="1">3.155</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>23</sub>H<sub>20</sub>O<sub>7</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">[M-H]<sup>&#x02212;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">407.1183</td><td align="center" valign="middle" rowspan="1" colspan="1">4.768</td><td align="center" valign="middle" rowspan="1" colspan="1">Isoflavonoids</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">19</td><td align="center" valign="middle" rowspan="1" colspan="1">7-methyl-1-[(2<italic toggle="yes">S</italic>,3<italic toggle="yes">R</italic>,4<italic toggle="yes">S</italic>,5<italic toggle="yes">S</italic>,6<italic toggle="yes">R</italic>)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1,5,6,7a-tetrahydrocyclopenta[c]pyran-4a,5,7-triol</td><td align="center" valign="middle" rowspan="1" colspan="1">4.053</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>15</sub>H<sub>24</sub>O<sub>10</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">[M-H]<sup>&#x02212;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">363.1290</td><td align="center" valign="middle" rowspan="1" colspan="1">0.588</td><td align="center" valign="middle" rowspan="1" colspan="1">Glycosides</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">20</td><td align="center" valign="middle" rowspan="1" colspan="1">Benzoic acid <sup>&#x02020;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">6.132</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>13</sub>H<sub>16</sub>O<sub>8</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">[M-H]<sup>&#x02212;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">137.0243</td><td align="center" valign="middle" rowspan="1" colspan="1">0.206</td><td align="center" valign="middle" rowspan="1" colspan="1">Organic acids</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">21</td><td align="center" valign="middle" rowspan="1" colspan="1">Neochlorogenic acid <sup>&#x02020;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">6.154</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>16</sub>H<sub>18</sub>O<sub>9</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">[M-H]<sup>&#x02212;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">353.0873</td><td align="center" valign="middle" rowspan="1" colspan="1">1.699</td><td align="center" valign="middle" rowspan="1" colspan="1">Organic acids</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">22</td><td align="center" valign="middle" rowspan="1" colspan="1">[(2<italic toggle="yes">R</italic>,3<italic toggle="yes">S</italic>,4<italic toggle="yes">S</italic>,5<italic toggle="yes">R</italic>,6<italic toggle="yes">S</italic>)-6-(3,4-dihydroxybenzoyl)oxy-3,4,5-trihydroxyoxan-2-yl]methyl 3,4-dihydroxybenzoate</td><td align="center" valign="middle" rowspan="1" colspan="1">6.189</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>20</sub>H<sub>20</sub>O<sub>12</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">[M-H]<sup>&#x02212;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">451.2175</td><td align="center" valign="middle" rowspan="1" colspan="1">4.395</td><td align="center" valign="middle" rowspan="1" colspan="1">Phenylglycosides</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">23</td><td align="center" valign="middle" rowspan="1" colspan="1">Chlorogenic acid <sup>&#x02020;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">6.652</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>167</sub>H<sub>18</sub>O<sub>9</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">[M-H]<sup>&#x02212;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">353.0872</td><td align="center" valign="middle" rowspan="1" colspan="1">0.824</td><td align="center" valign="middle" rowspan="1" colspan="1">Phenolics</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">24</td><td align="center" valign="middle" rowspan="1" colspan="1">2-[(4-Hydroxy-3,5-dimethoxyphenyl)methoxy]-6-(hydroxymethyl)oxane-3,4,5-triol</td><td align="center" valign="middle" rowspan="1" colspan="1">6.936</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>15</sub>H<sub>22</sub>O<sub>9</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">[M-H]<sup>&#x02212;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">345.1186</td><td align="center" valign="middle" rowspan="1" colspan="1">0.459</td><td align="center" valign="middle" rowspan="1" colspan="1">Glycosides</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">25</td><td align="center" valign="middle" rowspan="1" colspan="1">7-methyl-1-[(2<italic toggle="yes">S</italic>,3<italic toggle="yes">R</italic>,4<italic toggle="yes">S</italic>,5<italic toggle="yes">S</italic>,6<italic toggle="yes">R</italic>)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1,4a,5,6,7,7a-hexahydrocyclopenta[c]pyran-4-carboxylic acid</td><td align="center" valign="middle" rowspan="1" colspan="1">6.936</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>16</sub>H<sub>24</sub>O<sub>9</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">[M-H]<sup>&#x02212;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">405.1397</td><td align="center" valign="middle" rowspan="1" colspan="1">0.480</td><td align="center" valign="middle" rowspan="1" colspan="1">Terpenoids</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">26</td><td align="center" valign="middle" rowspan="1" colspan="1">9,13-Dihydroxy-4-megastigmen-3-one 9-glucoside</td><td align="center" valign="middle" rowspan="1" colspan="1">7.152</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>19</sub>H<sub>32</sub>O<sub>8</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">[M+HCOO]<sup>&#x02212;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">433.2071</td><td align="center" valign="middle" rowspan="1" colspan="1">1.882</td><td align="center" valign="middle" rowspan="1" colspan="1">Terpenoids</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">27</td><td align="center" valign="middle" rowspan="1" colspan="1">4-(<italic toggle="yes">&#x003b2;</italic>-D-Glucopyranosyloxy)benzyl 2,3-dihydroxy-3-methylbutanoate</td><td align="center" valign="middle" rowspan="1" colspan="1">7.220</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>18</sub>H<sub>26</sub>O<sub>10</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">[M+HCOO]<sup>&#x02212;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">447.1503</td><td align="center" valign="middle" rowspan="1" colspan="1">0.436</td><td align="center" valign="middle" rowspan="1" colspan="1">Organic acids</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">28</td><td align="center" valign="middle" rowspan="1" colspan="1">7-<italic toggle="yes">Epi</italic>-12-hydroxyjasmonic acid glucoside</td><td align="center" valign="middle" rowspan="1" colspan="1">7.371</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>18</sub>H<sub>28</sub>O<sub>9</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">[M-H]<sup>&#x02212;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">387.1655</td><td align="center" valign="middle" rowspan="1" colspan="1">0.551</td><td align="center" valign="middle" rowspan="1" colspan="1">Glycosides</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">29</td><td align="center" valign="middle" rowspan="1" colspan="1">Epigallocatechin <sup>&#x02020;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">7.395</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>15</sub>H<sub>14</sub>O<sub>7</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">[M-H]<sup>&#x02212;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">305.0699</td><td align="center" valign="middle" rowspan="1" colspan="1">3.288</td><td align="center" valign="middle" rowspan="1" colspan="1">Flavanols</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">30</td><td align="center" valign="middle" rowspan="1" colspan="1">5-hydroxy-2,2,6,6-tetramethyl-4-[2-methyl-1-[2,4,6-trihydroxy-3-(2-methylpropanoyl)phenyl]propyl]cyclohex-4-ene-1,3-dione</td><td align="center" valign="middle" rowspan="1" colspan="1">7.406</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>24</sub>H<sub>32</sub>O<sub>7</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">[M-H]<sup>&#x02212;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">431.1915</td><td align="center" valign="middle" rowspan="1" colspan="1">4.226</td><td align="center" valign="middle" rowspan="1" colspan="1">Fatty acids</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">31</td><td align="center" valign="middle" rowspan="1" colspan="1">Methyl 2,4,10-triacetyloxy-5,9-dihydroxy-1,4a-dimethyl-7-propan-2-yl-2,3,4,9,10,10a-hexahydrophenanthrene-1-carboxylate</td><td align="center" valign="middle" rowspan="1" colspan="1">7.406</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>27</sub>H<sub>36</sub>O<sub>10</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">[M-H]<sup>&#x02212;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">519.2437</td><td align="center" valign="middle" rowspan="1" colspan="1">0.771</td><td align="center" valign="middle" rowspan="1" colspan="1">Sesquiterpenes</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">32</td><td align="center" valign="middle" rowspan="1" colspan="1">Aesculetin</td><td align="center" valign="middle" rowspan="1" colspan="1">7.486</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>9</sub>H<sub>6</sub>O<sub>4</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">[M-H]<sup>&#x02212;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">177.0190</td><td align="center" valign="middle" rowspan="1" colspan="1">0.244</td><td align="center" valign="middle" rowspan="1" colspan="1">Coumarins</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">33</td><td align="center" valign="middle" rowspan="1" colspan="1">Oregonoyl A</td><td align="center" valign="middle" rowspan="1" colspan="1">7.509</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>33</sub>H<sub>36</sub>O<sub>12</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">[M-H]<sup>&#x02212;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">623.2188</td><td align="center" valign="middle" rowspan="1" colspan="1">4.846</td><td align="center" valign="middle" rowspan="1" colspan="1">Phenylglycosides</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">34</td><td align="center" valign="middle" rowspan="1" colspan="1">Chrysophanol</td><td align="center" valign="middle" rowspan="1" colspan="1">7.531</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>15</sub>H<sub>10</sub>O<sub>4</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">[M-H]<sup>&#x02212;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">253.0713</td><td align="center" valign="middle" rowspan="1" colspan="1">2.260</td><td align="center" valign="middle" rowspan="1" colspan="1">Quinones</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">35</td><td align="center" valign="middle" rowspan="1" colspan="1">Phenylacetic acid</td><td align="center" valign="middle" rowspan="1" colspan="1">7.676</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>8</sub>H<sub>8</sub>O<sub>2</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">[M-H]<sup>&#x02212;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">135.0451</td><td align="center" valign="middle" rowspan="1" colspan="1">0.048</td><td align="center" valign="middle" rowspan="1" colspan="1">Organic acids</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">36</td><td align="center" valign="middle" rowspan="1" colspan="1">3-(4-Hydroxyphenyl)pyruvic acid</td><td align="center" valign="middle" rowspan="1" colspan="1">7.676</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>9</sub>H<sub>8</sub>O<sub>4</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">[M-H]<sup>&#x02212;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">179.0347</td><td align="center" valign="middle" rowspan="1" colspan="1">0.249</td><td align="center" valign="middle" rowspan="1" colspan="1">Organic acids</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">37</td><td align="center" valign="middle" rowspan="1" colspan="1">Unknown</td><td align="center" valign="middle" rowspan="1" colspan="1">7.709</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">[M-H]<sup>&#x02212;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">601.2348</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">38</td><td align="center" valign="middle" rowspan="1" colspan="1">Bonanniol A</td><td align="center" valign="middle" rowspan="1" colspan="1">7.742</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>25</sub>H<sub>28</sub>O<sub>6</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">[M-H]<sup>&#x02212;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">423.1866</td><td align="center" valign="middle" rowspan="1" colspan="1">4.618</td><td align="center" valign="middle" rowspan="1" colspan="1">Dihydroflavonols</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">39</td><td align="center" valign="middle" rowspan="1" colspan="1">(2E)-4-Hydroxy-3,4-dimethyl-2-penten-1-yl 6-O-[(2S,3R,4R)-3,4-dihydroxy-4-(hydroxymethyl)tetrahydro-2-furanyl]-&#x003b2;-D-glucopyranoside</td><td align="center" valign="middle" rowspan="1" colspan="1">7.742</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>18</sub>H<sub>32</sub>O<sub>11</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">[M+HCOO]<sup>&#x02212;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">469.1921</td><td align="center" valign="middle" rowspan="1" colspan="1">0.527</td><td align="center" valign="middle" rowspan="1" colspan="1">Glycosides</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">40</td><td align="center" valign="middle" rowspan="1" colspan="1">1H-3,9a-Methanocyclopent[c]oxocin-4-carboxylic acid, 3,4,5,6,6a,9-hexahydro-4-hydroxy-7-(1-hydroxy-1-methylethyl)-</td><td align="center" valign="middle" rowspan="1" colspan="1">7.753</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>15</sub>H<sub>22</sub>O<sub>5</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">[M-H]<sup>&#x02212;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">281.1389</td><td align="center" valign="middle" rowspan="1" colspan="1">0.477</td><td align="center" valign="middle" rowspan="1" colspan="1">Organic acids</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">41</td><td align="center" valign="middle" rowspan="1" colspan="1">Flavovilloside</td><td align="center" valign="middle" rowspan="1" colspan="1">7.786</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>33</sub>H<sub>40</sub>O<sub>20</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">[M-H]<sup>&#x02212;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">755.2026</td><td align="center" valign="middle" rowspan="1" colspan="1">1.337</td><td align="center" valign="middle" rowspan="1" colspan="1">Flavonoid glycosides</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">42</td><td align="center" valign="middle" rowspan="1" colspan="1">Strobide B</td><td align="center" valign="middle" rowspan="1" colspan="1">7.831</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>11</sub>H<sub>10</sub>O<sub>7</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">[M-H]<sup>&#x02212;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">253.0351</td><td align="center" valign="middle" rowspan="1" colspan="1">0.233</td><td align="center" valign="middle" rowspan="1" colspan="1">Phenolics</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">43</td><td align="center" valign="middle" rowspan="1" colspan="1">Manghaslin</td><td align="center" valign="middle" rowspan="1" colspan="1">8.213</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>33</sub>H<sub>40</sub>O<sub>20</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">[M-H]<sup>&#x02212;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">755.2034</td><td align="center" valign="middle" rowspan="1" colspan="1">0.549</td><td align="center" valign="middle" rowspan="1" colspan="1">Flavonoid glycosides</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">44</td><td align="center" valign="middle" rowspan="1" colspan="1">2,3-dihydroxy-4-methoxy-4&#x02032;-ethoxybenzophenone</td><td align="center" valign="middle" rowspan="1" colspan="1">8.214</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>16</sub>H<sub>16</sub>O<sub>5</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">[M-H]<sup>&#x02212;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">287.1500</td><td align="center" valign="middle" rowspan="1" colspan="1">3.949</td><td align="center" valign="middle" rowspan="1" colspan="1">Fatty acids</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">45</td><td align="center" valign="middle" rowspan="1" colspan="1">3-<italic toggle="yes">O</italic>-Feruloylquinic acid <sup>&#x02020;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">8.378</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>33</sub>H<sub>40</sub>O<sub>20</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">[M-H]<sup>&#x02212;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">367.1028</td><td align="center" valign="middle" rowspan="1" colspan="1">0.183</td><td align="center" valign="middle" rowspan="1" colspan="1">Organic acids</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">46</td><td align="center" valign="middle" rowspan="1" colspan="1">Caffeic acid <sup>&#x02020;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">8.410</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>9</sub>H<sub>8</sub>O<sub>4</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">[M-H<sub>2</sub>O-H]<sup>&#x02212;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">179.0347</td><td align="center" valign="middle" rowspan="1" colspan="1">0.170</td><td align="center" valign="middle" rowspan="1" colspan="1">Organic acids</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">47</td><td align="center" valign="middle" rowspan="1" colspan="1">Unknown</td><td align="center" valign="middle" rowspan="1" colspan="1">8.410</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">[M-H]<sup>&#x02212;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">591.0980</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">48</td><td align="center" valign="middle" rowspan="1" colspan="1">Vanillylmandelic acid</td><td align="center" valign="middle" rowspan="1" colspan="1">8.419</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>9</sub>H<sub>10</sub>O<sub>5</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">[M-H]<sup>&#x02212;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">197.0454</td><td align="center" valign="middle" rowspan="1" colspan="1">0.100</td><td align="center" valign="middle" rowspan="1" colspan="1">Organic acids</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">49</td><td align="center" valign="middle" rowspan="1" colspan="1">[(2<italic toggle="yes">S</italic>,3<italic toggle="yes">S</italic>)-2-[(<italic toggle="yes">E</italic>,3<italic toggle="yes">R</italic>,4<italic toggle="yes">S</italic>)-3,4-dihydroxypent-1-enyl]-6-oxo-2,3-dihydropyran-3-yl] (<italic toggle="yes">E</italic>)-2-methylbut-2-enoate</td><td align="center" valign="middle" rowspan="1" colspan="1">8.419</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>15</sub>H<sub>20</sub>O<sub>6</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">[M-H]<sup>&#x02212;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">295.1184</td><td align="center" valign="middle" rowspan="1" colspan="1">0.242</td><td align="center" valign="middle" rowspan="1" colspan="1">Monoterpenoids</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">50</td><td align="center" valign="middle" rowspan="1" colspan="1">(-)-12-hydroxyjasmonic acid</td><td align="center" valign="middle" rowspan="1" colspan="1">8.584</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>12</sub>H<sub>18</sub>O<sub>4</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">[M-H]<sup>&#x02212;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">225.1133</td><td align="center" valign="middle" rowspan="1" colspan="1">0.414</td><td align="center" valign="middle" rowspan="1" colspan="1">Fatty acids</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">51</td><td align="center" valign="middle" rowspan="1" colspan="1">Coumaroyl quinic acid <sup>&#x02020;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">8.752</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>16</sub>H<sub>18</sub>O<sub>8</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">[M-H]<sup>&#x02212;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">337.0927</td><td align="center" valign="middle" rowspan="1" colspan="1">0.702</td><td align="center" valign="middle" rowspan="1" colspan="1">Organic acids</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">52</td><td align="center" valign="middle" rowspan="1" colspan="1">3-[4,5-dihydroxy-3-[(2<italic toggle="yes">R</italic>,3<italic toggle="yes">R</italic>,4<italic toggle="yes">R</italic>,5<italic toggle="yes">R</italic>,6<italic toggle="yes">S</italic>)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy-6-[[(2<italic toggle="yes">R</italic>,3<italic toggle="yes">R</italic>,4<italic toggle="yes">R</italic>,5<italic toggle="yes">R</italic>,6<italic toggle="yes">S</italic>)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxy-5,7-dihydroxy-2-(4-hydroxyphenyl)chromen-4-one</td><td align="center" valign="middle" rowspan="1" colspan="1">8.808</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>33</sub>H<sub>40</sub>O<sub>19</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">[M-H]<sup>&#x02212;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">739.2083</td><td align="center" valign="middle" rowspan="1" colspan="1">0.671</td><td align="center" valign="middle" rowspan="1" colspan="1">Flavonoid glycosides</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">53</td><td align="center" valign="middle" rowspan="1" colspan="1">Quercetin 3-<italic toggle="yes">O</italic>-<italic toggle="yes">&#x003b1;</italic>-rhamnopyranosyl-(1-2)-<italic toggle="yes">&#x003b2;</italic>-galactopyranoside</td><td align="center" valign="middle" rowspan="1" colspan="1">8.899</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>27</sub>H<sub>30</sub>O<sub>16</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">[M-H]<sup>&#x02212;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">609.1454</td><td align="center" valign="middle" rowspan="1" colspan="1">0.860</td><td align="center" valign="middle" rowspan="1" colspan="1">Flavonoid glycosides</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">54</td><td align="center" valign="middle" rowspan="1" colspan="1">Rutin <sup>&#x02020;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">9.405</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>27</sub>H<sub>30</sub>O<sub>16</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">[M-H]<sup>&#x02212;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">609.1454</td><td align="center" valign="middle" rowspan="1" colspan="1">0.321</td><td align="center" valign="middle" rowspan="1" colspan="1">Flavonoid glycosides</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">55</td><td align="center" valign="middle" rowspan="1" colspan="1">[(2<italic toggle="yes">R</italic>,3<italic toggle="yes">R</italic>,4<italic toggle="yes">R</italic>,5<italic toggle="yes">R</italic>,6<italic toggle="yes">R</italic>)-2-[[(2<italic toggle="yes">R</italic>,3<italic toggle="yes">R</italic>,4<italic toggle="yes">R</italic>)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxymethyl]-4-[(2<italic toggle="yes">S</italic>,3<italic toggle="yes">R</italic>,4<italic toggle="yes">R</italic>,5<italic toggle="yes">R</italic>,6<italic toggle="yes">S</italic>)-4,5-dihydroxy-6-methyl-3-[(2<italic toggle="yes">S</italic>,3<italic toggle="yes">R</italic>,4<italic toggle="yes">S</italic>,5<italic toggle="yes">S</italic>)-3,4,5-trihydroxyoxan-2-yl]oxyoxan-2-yl]oxy-6-[2-(3,4-dihydroxyphenyl)ethoxy]-5-hydroxyoxan-3-yl] (<italic toggle="yes">E</italic>)-3-(3,4-dihydroxyphenyl)prop-2-enoate</td><td align="center" valign="middle" rowspan="1" colspan="1">9.415</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>34</sub>H<sub>44</sub>O<sub>19</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">[M-H]<sup>&#x02212;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">755.2395</td><td align="center" valign="middle" rowspan="1" colspan="1">1.025</td><td align="center" valign="middle" rowspan="1" colspan="1">Phenylglycosides</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">56</td><td align="center" valign="middle" rowspan="1" colspan="1">Kaempferol 3-<italic toggle="yes">O</italic>-neohesperidoside <sup>&#x02020;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">9.596</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>30</sub>H<sub>26</sub>O<sub>13</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">[M-H]<sup>&#x02212;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">593.1505</td><td align="center" valign="middle" rowspan="1" colspan="1">0.488</td><td align="center" valign="middle" rowspan="1" colspan="1">Flavonoid glycosides</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">57</td><td align="center" valign="middle" rowspan="1" colspan="1">Acteoside</td><td align="center" valign="middle" rowspan="1" colspan="1">9.705</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>29</sub>H<sub>36</sub>O<sub>15</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">[M-H]<sup>&#x02212;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">623.1972</td><td align="center" valign="middle" rowspan="1" colspan="1">1.668</td><td align="center" valign="middle" rowspan="1" colspan="1">Phenylglycosides</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">58</td><td align="center" valign="middle" rowspan="1" colspan="1">Quercetin-3-<italic toggle="yes">O</italic>-galactoside</td><td align="center" valign="middle" rowspan="1" colspan="1">9.896</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>21</sub>H<sub>20</sub>O<sub>12</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">[M-H]<sup>&#x02212;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">463.0875</td><td align="center" valign="middle" rowspan="1" colspan="1">1.265</td><td align="center" valign="middle" rowspan="1" colspan="1">Flavonoid glycosides</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">59</td><td align="center" valign="middle" rowspan="1" colspan="1">Ferulic acid <sup>&#x02020;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">10.343</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>10</sub>H<sub>10</sub>O<sub>4</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">[M-H]<sup>&#x02212;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">193.0504</td><td align="center" valign="middle" rowspan="1" colspan="1">0.224</td><td align="center" valign="middle" rowspan="1" colspan="1">Phenolics</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">60</td><td align="center" valign="middle" rowspan="1" colspan="1">Quercetin-3-<italic toggle="yes">O</italic>-pentosyl(1-2)acetylpentoside</td><td align="center" valign="middle" rowspan="1" colspan="1">10.386</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>27</sub>H<sub>28</sub>O<sub>16</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">[M-H]<sup>&#x02212;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">607.1293</td><td align="center" valign="middle" rowspan="1" colspan="1">1.106</td><td align="center" valign="middle" rowspan="1" colspan="1">Flavonoid glycosides</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">61</td><td align="center" valign="middle" rowspan="1" colspan="1">(6<italic toggle="yes">R</italic>,9<italic toggle="yes">S</italic>)-3-o<italic toggle="yes">xo</italic>-&#x003b1;-ionol glucoside</td><td align="center" valign="middle" rowspan="1" colspan="1">10.517</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>19</sub>H<sub>30</sub>O<sub>7</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">[M+HCOO]<sup>&#x02212;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">415.1970</td><td align="center" valign="middle" rowspan="1" colspan="1">0.371</td><td align="center" valign="middle" rowspan="1" colspan="1">Terpenoids</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">62</td><td align="center" valign="middle" rowspan="1" colspan="1">[6-[2-(3,4-dihydroxyphenyl)ethoxy]-2-(hydroxymethyl)-4-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy-5-(3,4,5-trihydroxyoxan-2-yl)oxyoxan-3-yl] (<italic toggle="yes">E</italic>)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate</td><td align="center" valign="middle" rowspan="1" colspan="1">10.529</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>35</sub>H<sub>46</sub>O<sub>19</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">[M-H]<sup>&#x02212;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">769.2544</td><td align="center" valign="middle" rowspan="1" colspan="1">1.693</td><td align="center" valign="middle" rowspan="1" colspan="1">Phenylglycosides</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">63</td><td align="center" valign="middle" rowspan="1" colspan="1">Unknown</td><td align="center" valign="middle" rowspan="1" colspan="1">10.716</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">[M-H]<sup>&#x02212;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">629.2650</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">64</td><td align="center" valign="middle" rowspan="1" colspan="1">Quercetin-3-<italic toggle="yes">O</italic>-xyloside</td><td align="center" valign="middle" rowspan="1" colspan="1">10.774</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>20</sub>H<sub>18</sub>O<sub>11</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">[M-H]<sup>&#x02212;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">433.0769</td><td align="center" valign="middle" rowspan="1" colspan="1">1.099</td><td align="center" valign="middle" rowspan="1" colspan="1">Flavonoid glycosides</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">65</td><td align="center" valign="middle" rowspan="1" colspan="1">3-[(2<italic toggle="yes">S</italic>,3<italic toggle="yes">R</italic>,4<italic toggle="yes">R</italic>,5<italic toggle="yes">S</italic>)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-2-(3,4-dihydroxyphenyl)-5,7-dihydroxychromen-4-one</td><td align="center" valign="middle" rowspan="1" colspan="1">10.791</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>20</sub>H<sub>18</sub>O<sub>11</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">[M-H]<sup>&#x02212;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">433.07714</td><td align="center" valign="middle" rowspan="1" colspan="1">0.501</td><td align="center" valign="middle" rowspan="1" colspan="1">Flavonoid glycosides</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">66</td><td align="center" valign="middle" rowspan="1" colspan="1">Kaempferol-3-<italic toggle="yes">O</italic>-glucoside <sup>&#x02020;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">10.825</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>21</sub>H<sub>20</sub>O<sub>11</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">[M-H]<sup>&#x02212;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">447.09260</td><td align="center" valign="middle" rowspan="1" colspan="1">1.587</td><td align="center" valign="middle" rowspan="1" colspan="1">Flavonoid glycosides</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">67</td><td align="center" valign="middle" rowspan="1" colspan="1">[(2<italic toggle="yes">R</italic>,3<italic toggle="yes">S</italic>,4<italic toggle="yes">S</italic>,5<italic toggle="yes">R</italic>,6<italic toggle="yes">S</italic>)-6-(3,4-dihydroxybenzoyl)oxy-3,4,5-trihydroxyoxan-2-yl]methyl 3,4-dihydroxybenzoate</td><td align="center" valign="middle" rowspan="1" colspan="1">11.142</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>20</sub>H<sub>20</sub>O<sub>12</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">[M-H]<sup>&#x02212;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">451.2175</td><td align="center" valign="middle" rowspan="1" colspan="1">4.396</td><td align="center" valign="middle" rowspan="1" colspan="1">Phenylglycosides</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">68</td><td align="center" valign="middle" rowspan="1" colspan="1">Salidroside</td><td align="center" valign="middle" rowspan="1" colspan="1">11.185</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>14</sub>H<sub>20</sub>O<sub>7</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">[M-H]<sup>&#x02212;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">299.1138</td><td align="center" valign="middle" rowspan="1" colspan="1">0.188</td><td align="center" valign="middle" rowspan="1" colspan="1">Glycosides</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">69</td><td align="center" valign="middle" rowspan="1" colspan="1">6&#x02033;-<italic toggle="yes">O</italic>-(3-Hydroxy-3-methylglutaroyl)astragalin</td><td align="center" valign="middle" rowspan="1" colspan="1">11.426</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>27</sub>H<sub>28</sub>O<sub>15</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">[M-H]<sup>&#x02212;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">591.1347</td><td align="center" valign="middle" rowspan="1" colspan="1">0.491</td><td align="center" valign="middle" rowspan="1" colspan="1">Glycosides</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">70</td><td align="center" valign="middle" rowspan="1" colspan="1">Azelaic acid <sup>&#x02020;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">11.545</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>9</sub>H<sub>16</sub>O<sub>4</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">[M-H]<sup>&#x02212;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">187.0974</td><td align="center" valign="middle" rowspan="1" colspan="1">0.026</td><td align="center" valign="middle" rowspan="1" colspan="1">Organic acids</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">71</td><td align="center" valign="middle" rowspan="1" colspan="1">6-[(6,8-dihydroxy-7-methoxy-3-methyl-1-oxo-3,4-dihydroisochromen-4-yl)oxy]-4,8-dihydroxy-7-methoxy-3-methyl-3,4-dihydroisochromen-1-one</td><td align="center" valign="middle" rowspan="1" colspan="1">11.741</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>22</sub>H<sub>22</sub>O<sub>11</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">[M-H]<sup>&#x02212;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">461.1085</td><td align="center" valign="middle" rowspan="1" colspan="1">0.392</td><td align="center" valign="middle" rowspan="1" colspan="1">Quinones</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">72</td><td align="center" valign="middle" rowspan="1" colspan="1">Kaempferol-3-<italic toggle="yes">O</italic>-arabinoside <sup>&#x02020;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">11.842</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>20</sub>H<sub>18</sub>O<sub>10</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">[M-H]<sup>&#x02212;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">417.0822</td><td align="center" valign="middle" rowspan="1" colspan="1">0.794</td><td align="center" valign="middle" rowspan="1" colspan="1">Flavonoid glycosides</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">73</td><td align="center" valign="middle" rowspan="1" colspan="1"><italic toggle="yes">&#x003b2;</italic>-D-Glucopyranoside, 2-(3,4-dimethoxyphenyl)ethyl 3-<italic toggle="yes">O</italic>-(6-deoxy-alpha-L-mannopyranosyl)-4-<italic toggle="yes">O</italic>-[(2<italic toggle="yes">E</italic>)-3-(3,4-dihydroxyphenyl)-1-oxo-2-propen-1-yl]-6-<italic toggle="yes">O</italic>-[(2<italic toggle="yes">S</italic>,3<italic toggle="yes">R</italic>,4<italic toggle="yes">R</italic>)-tetrahydro-3,4-dihydroxy-4-(hydroxymethyl)-2-furanyl]-</td><td align="center" valign="middle" rowspan="1" colspan="1">11.886</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>36</sub>H<sub>48</sub>O<sub>19</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">[M-H]<sup>&#x02212;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">783.2706</td><td align="center" valign="middle" rowspan="1" colspan="1">1.131</td><td align="center" valign="middle" rowspan="1" colspan="1">Phenylglycosides</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">74</td><td align="center" valign="middle" rowspan="1" colspan="1">(5<italic toggle="yes">E</italic>)-3,4,9-trihydroxy-2-propyl-2,3,4,7,8,9-hexahydrooxecin-10-one</td><td align="center" valign="middle" rowspan="1" colspan="1">11.986</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>12</sub>H<sub>20</sub>O<sub>5</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">[M-H]<sup>&#x02212;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">243.1237</td><td align="center" valign="middle" rowspan="1" colspan="1">0.047</td><td align="center" valign="middle" rowspan="1" colspan="1">Polyketides</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">75</td><td align="center" valign="middle" rowspan="1" colspan="1">Tricin 5-glucoside</td><td align="center" valign="middle" rowspan="1" colspan="1">12.020</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>23</sub>H<sub>24</sub>O<sub>12</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">[M-H]<sup>&#x02212;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">491.1197</td><td align="center" valign="middle" rowspan="1" colspan="1">0.233</td><td align="center" valign="middle" rowspan="1" colspan="1">Flavonoid glycosides</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">76</td><td align="center" valign="middle" rowspan="1" colspan="1">Corylifol A</td><td align="center" valign="middle" rowspan="1" colspan="1">12.032</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>25</sub>H<sub>26</sub>O<sub>4</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">[M-H]<sup>&#x02212;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">389.1808</td><td align="center" valign="middle" rowspan="1" colspan="1">4.979</td><td align="center" valign="middle" rowspan="1" colspan="1">Flavonoids</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">77</td><td align="center" valign="middle" rowspan="1" colspan="1">2-Hydroxyanthraquinone</td><td align="center" valign="middle" rowspan="1" colspan="1">12.050</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>14</sub>H<sub>8</sub>O<sub>3</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">[M-H]<sup>&#x02212;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">223.0371</td><td align="center" valign="middle" rowspan="1" colspan="1">2.994</td><td align="center" valign="middle" rowspan="1" colspan="1">Phenols</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">78</td><td align="center" valign="middle" rowspan="1" colspan="1">Phyllanthin <sup>&#x02020;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">12.153</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>24</sub>H<sub>34</sub>O<sub>6</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">[M-H]<sup>&#x02212;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">417.2485</td><td align="center" valign="middle" rowspan="1" colspan="1">3.298</td><td align="center" valign="middle" rowspan="1" colspan="1">Phenylglycosides</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">79</td><td align="center" valign="middle" rowspan="1" colspan="1">[5-hydroxy-6-[2-(4-hydroxy-3-methoxyphenyl)ethoxy]-2-(hydroxymethyl)-4-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-3-yl] (<italic toggle="yes">E</italic>)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate</td><td align="center" valign="middle" rowspan="1" colspan="1">12.377</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>31</sub>H<sub>40</sub>O<sub>15</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">[M-H]<sup>&#x02212;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">651.2297</td><td align="center" valign="middle" rowspan="1" colspan="1">0.266</td><td align="center" valign="middle" rowspan="1" colspan="1">Phenylglycosides</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">80</td><td align="center" valign="middle" rowspan="1" colspan="1">[6-[2-(3,4-dihydroxyphenyl)-8-hydroxy-4-oxochromen-7-yl]oxy-3,4,5-trihydroxyoxan-2-yl]methyl (<italic toggle="yes">E</italic>)-3-(4-hydroxyphenyl)prop-2-enoate</td><td align="center" valign="middle" rowspan="1" colspan="1">13.741</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>30</sub>H<sub>26</sub>O<sub>13</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">[M-H]<sup>&#x02212;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">593.1293</td><td align="center" valign="middle" rowspan="1" colspan="1">0.451</td><td align="center" valign="middle" rowspan="1" colspan="1">Flavonoid glycosides</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">81</td><td align="center" valign="middle" rowspan="1" colspan="1">Tribuloside</td><td align="center" valign="middle" rowspan="1" colspan="1">14.111</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>30</sub>H<sub>26</sub>O<sub>13</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">[M-H]<sup>&#x02212;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">593.1293</td><td align="center" valign="middle" rowspan="1" colspan="1">0.732</td><td align="center" valign="middle" rowspan="1" colspan="1">Flavonoid glycosides</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">82</td><td align="center" valign="middle" rowspan="1" colspan="1">Unknown</td><td align="center" valign="middle" rowspan="1" colspan="1">14.289</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">[M-H]<sup>&#x02212;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">507.2697</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">83</td><td align="center" valign="middle" rowspan="1" colspan="1">Apigenin-7-neohesperidoside</td><td align="center" valign="middle" rowspan="1" colspan="1">14.559</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>27</sub>H<sub>30</sub>O<sub>14</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">[M-H]<sup>&#x02212;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">577.1638</td><td align="center" valign="middle" rowspan="1" colspan="1">3.592</td><td align="center" valign="middle" rowspan="1" colspan="1">Flavonoid glycosides</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">84</td><td align="center" valign="middle" rowspan="1" colspan="1">Procyanidin B2</td><td align="center" valign="middle" rowspan="1" colspan="1">14.943</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>30</sub>H<sub>26</sub>O<sub>12</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">[M-H]<sup>&#x02212;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">577.1346</td><td align="center" valign="middle" rowspan="1" colspan="1">0.451</td><td align="center" valign="middle" rowspan="1" colspan="1">Proanthocyanidin</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">85</td><td align="center" valign="middle" rowspan="1" colspan="1">(10<italic toggle="yes">E</italic>,15<italic toggle="yes">Z</italic>)-9,12,13-trihydroxyoctadeca-10,15-dienoic acid</td><td align="center" valign="middle" rowspan="1" colspan="1">15.402</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>18</sub>H<sub>32</sub>O<sub>5</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">[M-H]<sup>&#x02212;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">327.2173</td><td align="center" valign="middle" rowspan="1" colspan="1">0.880</td><td align="center" valign="middle" rowspan="1" colspan="1">Fatty acids</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">86</td><td align="center" valign="middle" rowspan="1" colspan="1">[(2<italic toggle="yes">R</italic>,3<italic toggle="yes">S</italic>,4<italic toggle="yes">S</italic>,5<italic toggle="yes">R</italic>,6<italic toggle="yes">S</italic>)-6-[2,3-dihydroxy-4-[(<italic toggle="yes">E</italic>)-3-(4-hydroxyphenyl)prop-2-enoyl]phenoxy]-3,4,5-trihydroxyoxan-2-yl]methyl (<italic toggle="yes">E</italic>)-3-(4-hydroxyphenyl)prop-2-enoate</td><td align="center" valign="middle" rowspan="1" colspan="1">15.452</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>30</sub>H<sub>28</sub>O<sub>12</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">[M-H]<sup>&#x02212;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">579.1497</td><td align="center" valign="middle" rowspan="1" colspan="1">0.571</td><td align="center" valign="middle" rowspan="1" colspan="1">Chalcones</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">87</td><td align="center" valign="middle" rowspan="1" colspan="1">1-(3,5-Dihydroxyphenyl)-12-hydroxytridecan-2-one</td><td align="center" valign="middle" rowspan="1" colspan="1">15.531</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>19</sub>H<sub>30</sub>O<sub>4</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">[M+HCOO]<sup>&#x02212;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">367.2118</td><td align="center" valign="middle" rowspan="1" colspan="1">0.806</td><td align="center" valign="middle" rowspan="1" colspan="1">Fatty acids</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">88</td><td align="center" valign="middle" rowspan="1" colspan="1">(<italic toggle="yes">Z</italic>)-9,12,13-trihydroxyoctadec-15-enoic acid</td><td align="center" valign="middle" rowspan="1" colspan="1">16.462</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>18</sub>H<sub>34</sub>O<sub>5</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">[M-H]<sup>&#x02212;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">329.2329</td><td align="center" valign="middle" rowspan="1" colspan="1">0.984</td><td align="center" valign="middle" rowspan="1" colspan="1">Fatty acids</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">89</td><td align="center" valign="middle" rowspan="1" colspan="1">Caperatic acid</td><td align="center" valign="middle" rowspan="1" colspan="1">16.512</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>21</sub>H<sub>38</sub>O<sub>7</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">[M-H]<sup>&#x02212;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">803.5136</td><td align="center" valign="middle" rowspan="1" colspan="1">2.373</td><td align="center" valign="middle" rowspan="1" colspan="1">Organic acids</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">90</td><td align="center" valign="middle" rowspan="1" colspan="1">Unknown</td><td align="center" valign="middle" rowspan="1" colspan="1">16.824</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">[M-H]<sup>&#x02212;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">473.2751</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">91</td><td align="center" valign="middle" rowspan="1" colspan="1">2-(2-Acetyloxy-12-hydroxytridecyl)-4,6-dihydroxybenzoic acid</td><td align="center" valign="middle" rowspan="1" colspan="1">17.308</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>22</sub>H<sub>34</sub>O<sub>7</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">[M-H]<sup>&#x02212;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">409.2223</td><td align="center" valign="middle" rowspan="1" colspan="1">1.304</td><td align="center" valign="middle" rowspan="1" colspan="1">Organic acids</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">92</td><td align="center" valign="middle" rowspan="1" colspan="1">Unknown</td><td align="center" valign="middle" rowspan="1" colspan="1">17.308</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">[M-H]<sup>&#x02212;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">819.4519</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">93</td><td align="center" valign="middle" rowspan="1" colspan="1">2-(2-Hydroxybut-3-en-2-yl)-3a,6,6,9a-tetramethyl-2,4,5,5a,7,8,9,9b-octahydro-1H-benzo[e][1]benzofuran-4,5-diol</td><td align="center" valign="middle" rowspan="1" colspan="1">17.523</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>20</sub>H<sub>34</sub>O<sub>4</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">[M-H]<sup>&#x02212;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">337.2383</td><td align="center" valign="middle" rowspan="1" colspan="1">0.076</td><td align="center" valign="middle" rowspan="1" colspan="1">Organic acids</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">94</td><td align="center" valign="middle" rowspan="1" colspan="1">[4,5-Dihydroxy-3,4-bis(hydroxymethyl)-4a,8,8-trimethyl-5,6,7,8a-tetrahydro-1H-naphthalen-1-yl] hexanoate</td><td align="center" valign="middle" rowspan="1" colspan="1">17.523</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>21</sub>H<sub>36</sub>O<sub>6</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">[M-H]<sup>&#x02212;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">383.2437</td><td align="center" valign="middle" rowspan="1" colspan="1">0.180</td><td align="center" valign="middle" rowspan="1" colspan="1">Fatty acids</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">95</td><td align="center" valign="middle" rowspan="1" colspan="1">Unknown</td><td align="center" valign="middle" rowspan="1" colspan="1">18.063</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">[M-H]<sup>&#x02212;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">441.2488</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">96</td><td align="center" valign="middle" rowspan="1" colspan="1">Aceroside VIII</td><td align="center" valign="middle" rowspan="1" colspan="1">18.131</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>30</sub>H<sub>42</sub>O<sub>12</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">[M-H]<sup>&#x02212;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">593.2626</td><td align="center" valign="middle" rowspan="1" colspan="1">2.264</td><td align="center" valign="middle" rowspan="1" colspan="1">Glycosides</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">97</td><td align="center" valign="middle" rowspan="1" colspan="1">Unknown</td><td align="center" valign="middle" rowspan="1" colspan="1">18.295</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">[M-H]<sup>&#x02212;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">473.2752</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">98</td><td align="center" valign="middle" rowspan="1" colspan="1">9,10-Epoxy-13-<italic toggle="yes">oxo</italic>-11-octadecenoic acid</td><td align="center" valign="middle" rowspan="1" colspan="1">18.343</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>18</sub>H<sub>30</sub>O<sub>4</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">[M-H]<sup>&#x02212;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">309.2070</td><td align="center" valign="middle" rowspan="1" colspan="1">1.042</td><td align="center" valign="middle" rowspan="1" colspan="1">Fatty acids</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">99</td><td align="center" valign="middle" rowspan="1" colspan="1">Unknown</td><td align="center" valign="middle" rowspan="1" colspan="1">18.372</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">[M-H]<sup>&#x02212;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">491.2750</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">100</td><td align="center" valign="middle" rowspan="1" colspan="1">2-(3-(8-Hydroxyoctyl)phenoxy)-2-methylpropanoic acid</td><td align="center" valign="middle" rowspan="1" colspan="1">19.466</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>18</sub>H<sub>28</sub>O<sub>4</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">[M-H]<sup>&#x02212;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">307.1910</td><td align="center" valign="middle" rowspan="1" colspan="1">0.409</td><td align="center" valign="middle" rowspan="1" colspan="1">Fatty acids</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">101</td><td align="center" valign="middle" rowspan="1" colspan="1">Forskolin</td><td align="center" valign="middle" rowspan="1" colspan="1">19.687</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>22</sub>H<sub>34</sub>O<sub>7</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">[M-H]<sup>&#x02212;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">409.2223</td><td align="center" valign="middle" rowspan="1" colspan="1">0.763</td><td align="center" valign="middle" rowspan="1" colspan="1">Diterpenes</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">102</td><td align="center" valign="middle" rowspan="1" colspan="1">3&#x02033;,4&#x02033;-Di-<italic toggle="yes">O</italic>-<italic toggle="yes">p</italic>-coumaroylafzelin</td><td align="center" valign="middle" rowspan="1" colspan="1">19.870</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>39</sub>H<sub>32</sub>O<sub>14</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">[M-H]<sup>&#x02212;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">723.1699</td><td align="center" valign="middle" rowspan="1" colspan="1">1.943</td><td align="center" valign="middle" rowspan="1" colspan="1">Flavonoids</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">103</td><td align="center" valign="middle" rowspan="1" colspan="1">Unknown</td><td align="center" valign="middle" rowspan="1" colspan="1">20.081</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">[M-H]<sup>&#x02212;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">489.2597</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">104</td><td align="center" valign="middle" rowspan="1" colspan="1">3-[(2<italic toggle="yes">S</italic>,3<italic toggle="yes">R</italic>,4<italic toggle="yes">S</italic>,5<italic toggle="yes">S</italic>,6<italic toggle="yes">R</italic>)-3-[(2<italic toggle="yes">S</italic>,3<italic toggle="yes">R</italic>,4<italic toggle="yes">R</italic>)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-5-hydroxy-2-(4-hydroxyphenyl)-7-[(2<italic toggle="yes">S</italic>,3<italic toggle="yes">R</italic>,4<italic toggle="yes">R</italic>,5<italic toggle="yes">R</italic>,6<italic toggle="yes">S</italic>)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxychromen-4-one</td><td align="center" valign="middle" rowspan="1" colspan="1">20.148</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>32</sub>H<sub>38</sub>O<sub>19</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">[M-H]<sup>&#x02212;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">725.1878</td><td align="center" valign="middle" rowspan="1" colspan="1">5.683</td><td align="center" valign="middle" rowspan="1" colspan="1">Flavonoid glycosides</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">105</td><td align="center" valign="middle" rowspan="1" colspan="1">Biochanin A</td><td align="center" valign="middle" rowspan="1" colspan="1">20.437</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>16</sub>H<sub>12</sub>O<sub>5</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">[M-H]<sup>&#x02212;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">283.0607</td><td align="center" valign="middle" rowspan="1" colspan="1">0.407</td><td align="center" valign="middle" rowspan="1" colspan="1">Isoflavone</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">106</td><td align="center" valign="middle" rowspan="1" colspan="1">1-<italic toggle="yes">Epi</italic> coleonol</td><td align="center" valign="middle" rowspan="1" colspan="1">20.475</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>22</sub>H<sub>34</sub>O<sub>7</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">[M-H]<sup>&#x02212;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">409.2224</td><td align="center" valign="middle" rowspan="1" colspan="1">0.793</td><td align="center" valign="middle" rowspan="1" colspan="1">Terpenoids</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">107</td><td align="center" valign="middle" rowspan="1" colspan="1">Amorfrutin</td><td align="center" valign="middle" rowspan="1" colspan="1">20.581</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>18</sub>H<sub>26</sub>O<sub>4</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">[M-H]<sup>&#x02212;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">305.1754</td><td align="center" valign="middle" rowspan="1" colspan="1">0.378</td><td align="center" valign="middle" rowspan="1" colspan="1">Terpenoids</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">108</td><td align="center" valign="middle" rowspan="1" colspan="1">[4,5-dihydroxy-3,4-bis(hydroxymethyl)-4a,8,8-trimethyl-5,6,7,8a-tetrahydro-1H-naphthalen-1-yl] octanoate</td><td align="center" valign="middle" rowspan="1" colspan="1">21.023</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>23</sub>H<sub>40</sub>O<sub>6</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">[M-H]<sup>&#x02212;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">457.2798</td><td align="center" valign="middle" rowspan="1" colspan="1">0.867</td><td align="center" valign="middle" rowspan="1" colspan="1">Fatty acids</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">109</td><td align="center" valign="middle" rowspan="1" colspan="1">Rotenone</td><td align="center" valign="middle" rowspan="1" colspan="1">21.292</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>23</sub>H<sub>22</sub>O<sub>6</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">[M-H]<sup>&#x02212;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">393.2271</td><td align="center" valign="middle" rowspan="1" colspan="1">0.143</td><td align="center" valign="middle" rowspan="1" colspan="1">Isoflavone</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">110</td><td align="center" valign="middle" rowspan="1" colspan="1">Nandrolone</td><td align="center" valign="middle" rowspan="1" colspan="1">22.280</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>18</sub>H<sub>26</sub>O<sub>2</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">[M-H<sub>2</sub>O-H]<sup>&#x02212;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">275.2015</td><td align="center" valign="middle" rowspan="1" colspan="1">1.519</td><td align="center" valign="middle" rowspan="1" colspan="1">Steroids</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">111</td><td align="center" valign="middle" rowspan="1" colspan="1">15,16-Epoxy-9,12-octadecadienoic acid</td><td align="center" valign="middle" rowspan="1" colspan="1">22.290</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>18</sub>H<sub>30</sub>O<sub>3</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">[M-H]<sup>&#x02212;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">293.2120</td><td align="center" valign="middle" rowspan="1" colspan="1">0.271</td><td align="center" valign="middle" rowspan="1" colspan="1">Fatty acids</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">112</td><td align="center" valign="middle" rowspan="1" colspan="1">2-Hydroxy-4,5&#x02032;,8a&#x02032;-trimethyl-1&#x02032;-oxo-4-vinyloctahydro-1&#x02032;H-spiro[cyclopentane-1,2&#x02032;-naphthalene]-5&#x02032;-carboxylic acid</td><td align="center" valign="middle" rowspan="1" colspan="1">22.588</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>20</sub>H<sub>30</sub>O<sub>4</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">[M-H]<sup>&#x02212;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">333.2071</td><td align="center" valign="middle" rowspan="1" colspan="1">0.005</td><td align="center" valign="middle" rowspan="1" colspan="1">Organic acids</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">113</td><td align="center" valign="middle" rowspan="1" colspan="1">Grayanotoxin I</td><td align="center" valign="middle" rowspan="1" colspan="1">22.830</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>22</sub>H<sub>36</sub>O<sub>7</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">[M-H<sub>2</sub>O-H]<sup>&#x02212;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">393.2276</td><td align="center" valign="middle" rowspan="1" colspan="1">0.176</td><td align="center" valign="middle" rowspan="1" colspan="1">Diterpenes</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">114</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9-Hydroxy-10<italic toggle="yes">E</italic>,12<italic toggle="yes">Z</italic>-octadecadienoic acid</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">22.962</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">C<sub>18</sub>H<sub>32</sub>O<sub>3</sub></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[M-H]<sup>&#x02212;</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">295.2272</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.636</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fatty acids</td></tr></tbody></table><table-wrap-foot><fn><p><sup>&#x02020;</sup> Reference standard. Other metabolites were identified by analyzing and comparing precursor and fragmentation ions to those obtained from public MS/MS databases for spectral matching.</p></fn></table-wrap-foot></table-wrap></floats-group></article>